Exhibit 2.1

                 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION

                                  by and among

                         CARDIOTECH INTERNATIONAL, INC.,

                             GISH ACQUISITION CORP.

                                       and

                              GISH BIOMEDICAL, INC.

                                October 25, 2002





















                     ELLENOFF GROSSMAN SCHOLE & CYRULI, LLP
                              370 Lexington Avenue
                            New York, New York 10017




                 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION

     THIS AGREEMENT AND PLAN OF MERGER AND  REORGANIZATION  (the "Agreement") is
made as of  October  25,  2002 (the  "Execution  Date") by and among  CARDIOTECH
INTERNATIONAL,  INC., a Massachusetts  corporation ("Parent"),  GISH ACQUISITION
CORP., a Delaware  corporation  ("Merger  Sub"),  and GISH  BIOMEDICAL,  INC., a
California corporation (the "Company").

                                    RECITALS

     A. The Boards of  Directors  of Parent,  Merger Sub and  Company  each have
determined that the business  combination between Parent and Company through the
merger of Merger Sub with and into the Company pursuant to the terms and subject
to the  conditions  set forth herein (the "Merger") is advisable and in the best
interests of their respective companies and shareholders.

     B. Merger Sub is a wholly-owned  subsidiary of Parent formed solely for the
purpose of engaging in the Merger.

     C. Pursuant to the Merger,  among other things,  (i) each outstanding share
of Company  Capital Stock (as  hereinafter  defined) shall be converted into the
right to receive  shares of common stock of Parent at the rate set forth herein,
and (ii) each outstanding share of common stock of Merger Sub shall be converted
into and exchanged for one validly issued,  fully paid and non-assessable  share
of common stock of the Surviving Corporation (as hereinafter defined).

     D.  The  Company  and  Parent  desire  to  make  certain   representations,
warranties, covenants and other agreements in connection with the Merger.

     E. The parties  intend,  by executing  this  Agreement,  to adopt a plan of
reorganization within the meaning of Section 368 of the Internal Revenue Code of
1986,  as  amended  (the  "Code"),  and to cause  the  Merger  to  qualify  as a
reorganization under the provisions of Sections 368(a) of the Code.

     F. As an  inducement  to  Parent  to enter  into  this  Agreement,  certain
officers,  directors and shareholders of the Company have concurrently  herewith
entered into an agreement to vote the shares of the Company  Capital Stock owned
by such persons to approve the Merger and this Agreement.

     NOW,  THEREFORE,  in consideration of the covenants and representations set
forth herein, and for other good and valuable  consideration,  the parties agree
as follows:





                                    ARTICLE I

                                   THE MERGER

     1.1 The Merger.  Subject to and in accordance with the terms and conditions
         ----------
set forth in this Agreement,  at the "Effective Time" (as defined in Section 1.2
hereof),  Merger Sub shall be merged with and into the  Company,  which shall be
the  surviving  corporation  ("Surviving  Corporation")  in the Merger,  and the
separate  existence of Merger Sub shall thereupon  cease.  The name of Surviving
Corporation shall be "Gish  Biomedical,  Inc." The Merger shall have the effects
set forth in the applicable  provisions of the Delaware General  Corporation Law
("Delaware Law") and the California General Corporation Law ("California Law").

     1.2 Closing;  Effective Time. The closing of the transactions  contemplated
         ------------------------
hereby (the "Closing")  shall take place as soon as practicable and in any event
not later than three business days after the  satisfaction  or waiver of each of
the  conditions  set forth in  Article  VI hereof or at such  other  time as the
parties hereto agree (the "Closing  Date").  The Closing shall take place at the
offices of Ellenoff  Grossman Schole & Cyruli,  LLP, 370 Lexington  Avenue,  New
York,  New York,  or at such other  location as the  parties  hereto  agree.  In
connection with the Closing, the parties hereto shall cause the Merger to become
effective at such time as a properly executed copy of the Certificate of Merger,
(the   "Certificate   of  Merger"),   together   with  any  required   officers'
certificates,  is duly  filed  with the  Secretaries  of State of the  States of
California  and  Delaware,   in  accordance  with  the  relevant  provisions  of
California  Law and Delaware  Law,  respectively,  or such later time upon which
Parent and  Company  may agree and set forth in the  Certificate  of Merger (the
time the Merger  becomes  effective  being  referred to herein as the "Effective
Time").

     1.3 Effect of the Merger.  At the Effective  Time, the effect of the Merger
         --------------------
shall be as provided  in this  Agreement,  the  Certificate  of Merger,  and the
applicable  provisions of California Law and Delaware Law.  Without limiting the
generality of the foregoing, and subject thereto, at the Effective Time, all the
property,  rights,  privileges,  powers and franchises of the Company and Merger
Sub shall vest in the  Surviving  Corporation,  and all debts,  liabilities  and
duties of the Company  and Merger Sub shall  become the debts,  liabilities  and
duties of the Surviving Corporation.

     1.4 Articles of Incorporation; Bylaws.
         ---------------------------------

     (a) At the Effective  Time,  the Articles of  Incorporation  of the Company
shall be the  Articles  of  Incorporation  of the  Surviving  Corporation  until
thereafter further amended as provided by California Law.

     (b) At the Effective Time, the Bylaws of the Company shall be the Bylaws of
the  Surviving  Corporation  until  thereafter  further  amended as  provided by
California Law and such Bylaws.

     1.5  Directors and Officers.  At the Effective  Time,  (i) the directors of
          ----------------------
Merger  Sub  shall  be the  directors  of  Surviving  Corporation,  until  their
respective successors are duly elected or appointed and qualified,  and (ii) the
officers of Merger Sub shall be the  officers of  Surviving  Corporation,  until
their respective successors are duly elected or appointed and qualified.

                                       2



     1.6 Effect on Capital Stock.
         -----------------------

     (a) Certain Definitions.
         -------------------

     "Company Capital Stock" shall mean all outstanding  shares of the Company's
      ---------------------
Common  Stock,  no par value,  and all  outstanding  shares of any other capital
stock of Company immediately prior to the Effective Time.

     "Company Common Stock" shall mean shares of the Common Stock, no par value,
      --------------------
of the Company.

     "Company  Options"  shall  mean  any and all  options  or other  rights  to
      ----------------
purchase or otherwise  acquire shares of Company  Capital Stock,  whether or not
presently  exercisable  or subject to additional  conditions  prior to exercise,
under  and  pursuant  to  its  (i)  Amended  1997  Stock  Incentive  Plan;  (ii)
Non-qualified  Stock Option  Agreement,  dated as of May 18, 2000, with Kelly D.
Scott; and (iii)  Non-qualified  Stock Option  Agreement,  dated as of August 8,
2001,   with  Kelly  D.  Scott  (each,   a  "Company  Stock  Option  Plan,"  and
collectively, the "Company Stock Option Plans").

     "Company  Preferred Stock" shall mean shares of the Preferred Stock, no par
      ------------------------
value, of the Company.

     "Exchange Ratio" shall mean 1.3422.
      --------------

     "Parent Closing Price" shall mean $1.5124.
      --------------------

     "Parent Common Stock" shall mean shares of the Common Stock, par value $.01
      -------------------
per share, of Parent.

     (b)  Conversion  of  Company  Capital  Stock.  By virtue of the  Merger and
          ---------------------------------------
without any further action on the part of Parent,  Company, Merger Sub or any of
their  respective  shareholders,  at the Effective  Time,  each share of Company
Capital Stock issued and  outstanding  immediately  prior to the Effective Time,
but  excluding  any  shares  canceled  pursuant  to  Section  1.6(c),   will  be
automatically canceled, extinguished and converted into the right to receive one
share of Parent  Common  Stock  multiplied  by the  Exchange  Ratio (the "Merger
Consideration").

     (c)  Cancellation  of  Company  Capital  Stock  Owned  by  Company.  At the
          -------------------------------------------------------------
Effective Time, all shares of Company Capital Stock that are owned by Company as
treasury stock and all shares of Company Capital Stock owned by Parent or Merger
Sub or any  direct  or  indirect  wholly-owned  subsidiary  of  Parent  shall be
canceled  and  extinguished  without  any rights to  conversion  thereof  and no
consideration shall be delivered in exchange therefor.

                                       3



     (d) Treatment of Company Option Plans and Company Options. At the Effective
         -----------------------------------------------------
Time,  the Company Stock Option Plans and all Company  Options then  outstanding
under the Company  Stock Option  Plans shall be assumed by Parent and  converted
into  options to  purchase  shares of Parent  Common  Stock in  accordance  with
Section 5.10 hereof.

     (e)  Adjustments  to  Exchange  Ratio.  The  Exchange  Ratio  shall only be
          --------------------------------
adjusted to reflect  fully the effect of any stock split,  reverse  stock split,
stock dividend (including any dividend or distribution of securities convertible
into  Parent  Common  Stock  or  Company   Capital   Stock),   reclassification,
reorganization,  recapitalization  or other like change  with  respect to Parent
Common Stock or Company Common Stock  occurring  after the date hereof and prior
to the Effective  Time, so as to provide  holders of Company  Common Stock,  and
Parent the same economic  effect as contemplated by this Agreement prior to such
stock split,  reverse split, stock dividend,  reorganization,  recapitalization,
like change or increase.

     (f) Fractional  Shares.  No fraction of a share of Parent Common Stock will
         ------------------
be issued,  but in lieu thereof,  each holder of shares of Company Capital Stock
who would  otherwise be entitled to a fraction of a share of Parent Common Stock
(after  aggregating all fractional  shares of Parent Common Stock to be received
by such  holder)  shall  receive  from Parent an amount of cash  (rounded to the
nearest  whole cent) equal to the product of (i) such  fraction,  multiplied  by
(ii) the Parent  Closing  Price,  less any amount  required to be withheld under
foreign, federal, state or local tax laws.

     (g)  Capital  Stock of Merger  Sub. At the  Effective  Time,  each share of
          -----------------------------
common  stock of Merger  Sub  issued and  outstanding  immediately  prior to the
Effective Time, together with the related stock certificate evidencing ownership
thereof, shall be converted into and exchanged for one (1) validly issued, fully
paid and non-assessable share of common stock of the Surviving Corporation and a
stock certificate evidencing ownership thereof.

                                        4



     1.7  Surrender  of   Certificates   Representing   Common   Capital  Stock.
          ----------------------------------------------------------------------

     (a) Exchange  Agent.  Parent's  transfer  agent,  American Stock Transfer &
         ---------------
Trust Company,  shall act as the exchange  agent (the  "Exchange  Agent") in the
Merger.

     (b) Parent to Provide  Common Stock and Cash.  Promptly after the Effective
         ----------------------------------------
Time,  Parent shall  deposit with the Exchange  Agent for exchange in accordance
with this Article I, through such reasonable procedures as Parent may adopt, (i)
the shares of Parent Common Stock issuable  pursuant to Section 1.6(b) (provided
that  delivery of any shares that are subject to vesting  shall be in book entry
form only until such vesting restrictions have lapsed) in exchange for shares of
Company Capital Stock  outstanding  immediately prior to the Effective Time, and
(ii)  cash  in an  amount  sufficient  to  permit  payment  of  cash  in lieu of
fractional  shares pursuant to Section 1.6(g),  less any amounts  required to be
withheld from such cash under foreign, federal, state or local laws.

     (c) Exchange Procedures.
         -------------------

     (i) As soon as  reasonably  practicable  after the Effective  Time,  Parent
shall  cause  to be  mailed  to  each  holder  of  record  of a  certificate  or
certificates (the "Certificates")  which immediately prior to the Effective Time
represented  outstanding  shares of Company  Capital  Stock,  whose  shares were
converted  into shares of Parent  Common  Stock (and cash in lieu of  fractional
shares,  less any amount  required to be withheld from such cash under  foreign,
federal, state or local tax laws), (1) a letter of transmittal in customary form
(which shall specify that delivery shall be effected, and risk of loss and title
to the  Certificates  shall pass,  only upon receipt of the  Certificates by the
Exchange Agent from the  shareholders of the Company,  and shall be in such form
(duly and properly  executed as may be required by Exchange Agent) and have such
other provisions as Parent may reasonably specify), and (2) instructions for use
in effecting the surrender of the  Certificates in exchange for certificates (or
book entries in the case of shares that have not yet vested) representing shares
of Parent Common Stock (and cash in lieu of fractional  shares,  less any amount
required to be withheld from such cash under  foreign,  federal,  state or local
tax laws).

     (ii) Upon surrender of a Certificate for cancellation to the Exchange Agent
or to such other agent or agents as may be  appointed by Parent,  together  with
such letter of  transmittal,  duly completed and validly  executed in accordance
with the  instructions  thereto,  (A) the  holder of such  Certificate  shall be
entitled to receive in exchange  therefor a certificate  (or a book entry in the
case of shares  that have not yet  vested in full)  representing  the  number of
whole  shares of Parent  Common  Stock equal to the product of (i) the number of
shares of Company Capital Stock  represented by such  Certificate  multiplied by
(ii) the Exchange Ratio, (B) if applicable, payment in lieu of fractional shares
which such holder has the right to receive  pursuant to Section 1.6(g),  and (C)
the Certificate so surrendered shall forthwith be canceled.


     (iii) In the event that any  Certificate  shall  have been lost,  stolen or
destroyed,  upon the  making of an  affidavit  of that  fact by  holder  thereof
claiming such  Certificate to be lost,  stolen or destroyed,  the Exchange Agent
will  issue or cause to be issued  to such  Person in  exchange  for such  lost,
stolen or destroyed Certificate, a new certificate into which the shares of such
Person's  Company Capital Stock that are converted at the Effective Time and/or,
if  applicable,  deliver  or cause  to be  delivered  to such  Person a check in
respect of any fractional share interests or dividends or  distributions,  which
such Person shall be entitled to receive  pursuant to Section 1.6(g),  excluding

                                       5



any payment  obligations which may have otherwise accrued prior to the Effective
Time. When  authorizing  such issuance in exchange  therefor,  Parent and/or the
Exchange  Agent may,  in its  discretion  and as a  condition  precedent  to the
issuance  thereof,  require  the  holder  of  such  lost,  stolen  or  destroyed
Certificate to give Parent and/or the Exchange  Agent a reasonable  form of bond
as  indemnity,  as it shall  direct,  against any claim that may be made against
Parent or the  Exchange  Agent with respect to the  Certificate  alleged to have
been lost, stolen or destroyed.

     (d) Distributions With Respect to Unexchanged Certificates. No dividends or
         ------------------------------------------------------
other distributions with respect to Parent Common Stock with a record date after
the Effective Time will be paid to the holder of any  unsurrendered  Certificate
with respect to the shares of Parent Common Stock represented  thereby until the
holder of record of such Certificate shall surrender such  Certificate.  Subject
to applicable law, following  surrender of any such Certificate,  there shall be
paid to the record holder of the Certificate representing whole shares of Parent
Common Stock issued in exchange therefor,  without interest, at the time of such
surrender, the amount of any such dividends or other distributions with a record
date after the Effective  Time  theretofore  payable (but for the  provisions of
this Section 1.7(d)) with respect to such shares of Parent Common Stock.

     (e) Transfers of Ownership.  If any certificate for shares of Parent Common
         ----------------------
Stock  is to be  issued  in a name  other  than  that in which  the  Certificate
surrendered in exchange  therefore is registered,  it will be a condition of the
issuance thereof that the Certificate so surrendered  will be properly  endorsed
and  otherwise in proper form for transfer and that the Person  requesting  such
exchange  will  have paid to the  Exchange  Agent,  Parent  or any  other  agent
designated by Parent,  as  applicable,  any transfer or other taxes  required by
reason of the issuance of a certificate for shares of Parent Common Stock in any
name other than that of the registered holder of the Certificate surrendered, or
established to the satisfaction of the Exchange Agent, Parent or any other agent
designated  by  Parent,  as  applicable,  that  such tax has been paid or is not
payable.

     (f) No Liability.  Notwithstanding anything to the contrary in this Section
         ------------
1.7, none of the Exchange  Agent,  Parent,  Surviving  Corporation  or any other
party  hereto  shall be liable to any Person for any amount  properly  paid to a
public  official  pursuant  to any  applicable  abandoned  property,  escheat or
similar law.

     1.8 No Further  Ownership  Rights in Company  Capital Stock.  All shares of
         -------------------------------------------------------
Parent  Common Stock issued upon the surrender for exchange of shares of Company
Capital Stock in accordance  with the terms hereof  (including  any cash paid in
lieu of  fractional  shares)  shall  be  deemed  to  have  been  issued  in full
satisfaction  of all rights  pertaining to such shares of Company Capital Stock,
and after the Effective Time there shall be no further registration of transfers
on the records of the Surviving  Corporation of shares of Company  Capital Stock
which were  outstanding  immediately  prior to the Effective Time. If, after the
Effective Time,  Certificates are presented to the Surviving Corporation for any
reason, they shall be exchanged and canceled as provided in this Article I.

                                       6



     1.9 Tax Consequences.  It is intended by the parties hereto that the Merger
         ----------------
shall constitute a reorganization within the meaning of Section 368 of the Code.

The  parties  to this  Agreement  hereby  adopt  this  Agreement  as a "plan  of
reorganization"  within the meaning of Sections 1.368-2(g) and 1.368-3(a) of the
United States Treasury Regulations.

     1.10  Withholding  Rights.  Parent and the Surviving  Corporation  shall be
           -------------------
entitled to deduct and withhold from the number of shares of Parent Common Stock
otherwise  deliverable  under this  Agreement,  and from any other payments made
pursuant to this Agreement, such amounts as Parent and the Surviving Corporation
are  required to deduct and withhold  with respect to such  delivery and payment
under the Code or any provision of state, local,  provincial or foreign tax law.
To the extent that  amounts are so  withheld,  such  withheld  amounts  shall be
treated for all purposes of this  Agreement as having been delivered and paid to
the holder of shares of Company Capital Stock in respect of which such deduction
and withholding was made by Parent and the Surviving Corporation.

     1.11 Taking of Necessary Action;  Further Action. If, at any time after the
          -------------------------------------------
Effective  Time,  any further  action is necessary or desirable to carry out the
purposes of this Agreement and to vest the Surviving Corporation with all right,
title and possession to all assets,  property,  rights,  privileges,  powers and
franchises  of the Company and its assets,  the  officers  and  directors of the
Company,  Parent and the Surviving  Corporation are fully authorized in the name
of their  respective  corporations or otherwise to take, and will take, all such
lawful and necessary  action,  so long as such action is not  inconsistent  with
this Agreement.

     1.12  Dissenters'  Rights of Appraisals.  Notwithstanding  anything in this
           ---------------------------------
Agreement to the contrary, each share of Company Common Stock that is issued and
outstanding  immediately  prior  to the  Effective  Time  and  that is held by a
Company  shareholder who has properly demanded and perfected such  shareholder's
rights to dissent, if applicable,  from the Merger and to be paid the fair value
of such shares in accordance  with  California  Law (the  "Dissenting  Shares"),
shall not be converted  into the right to receive the Parent Common  Stock,  but
the holder thereof shall be entitled to such rights as are granted by California
Law and  Surviving  Corporation  shall make all  payments to the holders of such
Dissenting  Shares with respect to such demands in  accordance  with  California
Law;  provided  however,  that if any such holder  shall,  prior to or after the
Effective  Time,  have failed to perfect or shall have lost the right to dissent
and obtain payment for such holder's  Dissenting  Shares under  California  Law,
each share of Company  Capital  Stock held by such  holder  shall  thereupon  be
deemed  automatically to have been converted into, as of the Effective Time, the
Parent Common Stock.  The Company shall give prompt written notice to Parent and
Merger Sub of any demands  received by the Company for payment under  California
Law,  and the Parent and Merger Sub shall have the right to  participate  in all
negotiations  and  proceedings  with respect to such demands.  The Company shall
not,  except with the prior  written  consent of Parent and Merger Sub, have any
meetings or make any payment with  respect to,  settle,  or offer to settle,  or
offer to make any payment to settle,  any such demands,  except that the Company
may make  payments  to settle  such  demands  to the  extent  that the per share
settlement amount does not exceed the Merger Consideration.


                                       7



                                   ARTICLE II

                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     In this Agreement,  any reference to any event, change, condition or effect
being  "material"  with  respect  to any entity or group of  entities  means any
material  event,  change,  condition  or  effect  on  the  financial  condition,
properties,  assets, liabilities,  business, operations or results of operations
of such entity and its subsidiaries taken as a whole.

     In this  Agreement,  any reference to a "Company  Material  Adverse Effect"
means any change,  event or effect that is  materially  adverse to the financial
condition,  properties, assets, liabilities,  business, operations or results of
operations of the Company; provided, however, that none of the following will be
deemed, individually or collectively,  to constitute a "Company Material Adverse
Effect:" (i) any changes, circumstances or effects resulting from or relating to
changes or developments in the economy,  financial  markets,  commodity markets,
laws,  regulations  or rules or in the  political  climate  generally  or in any
specific  region;  (ii) any  changes in  conditions  or  developments  generally
applicable  to the  industries  in which the Company is involved;  and (iii) any
changes,  circumstances or effects  attributable to the announcement or pendency
of the transactions  contemplated by this Agreement (including any cancellations
of or delays in customer agreements,  any reductions in sales, any disruption in
supplier,  distributor or similar  relationships  or any loss of employees),  or
resulting from or relating to compliance with the terms of, or the taking of any
action required by, this Agreement.

     In this  Agreement,  any  reference to a party's  "knowledge"  means,  with
respect to any  individual,  the actual  knowledge of such individual or, in the
case of any entity, the actual knowledge, without independent investigation,  of
the entity's officers and directors set forth on Schedule II.

     In this  Agreement,  any  reference to a party  conducting  its business or
other  affairs or taking any action in the "ordinary  course of business"  means
that such an action  taken by or on behalf of such party  shall not be deemed to
have been taken in the "ordinary course of business" unless such action is taken
in the  ordinary  course of such  party's  normal day to day  operations  and is
similar in nature  and  magnitude  to actions  customarily  taken,  without  any
separate or special authorization.

     Except as  disclosed  in any Company  SEC  Document  or as  disclosed  in a
document of even date  herewith and attached to this  Agreement and delivered by
the Company to Parent prior to the execution and delivery of this  Agreement and
referring  by  section  number to the  representations  and  warranties  in this
Agreement  (the "Company  Disclosure  Schedule"),  provided that any  disclosure
shall qualify the disclosure under the section number referred to in the Company
Disclosure Schedule as well as all other sections in this Agreement,  when it is
reasonably  apparent from a reading of such disclosure that it also qualifies or
applies to such other sections, provided further that the Company shall make all
reasonable  efforts to specifically  cross  reference in the Company  Disclosure
Schedule all sections where a particular  disclosure  qualifies or applies,  the
Company represents and warrants to Parent and Surviving Corporation as follows:

                                       8



     2.1  Organization,  Standing and Power.  The Company is a corporation  duly
          ---------------------------------
organized,  validly  existing  and  in  good  standing  under  the  laws  of its
jurisdiction  of  organization.  The Company has the corporate  power to own its
properties and to carry on its business as now being  conducted and as currently
proposed to be  conducted  and is duly  qualified  to do business and is in good
standing in each  jurisdiction in which the failure to be so qualified and to be
in good standing would have a Company Material  Adverse Effect.  The Company has
delivered  or  made  available  a true  and  correct  copy  of the  Articles  of
Incorporation and Bylaws of the Company,  each as amended to the Execution Date,
to Parent.  The  Company is not in  violation  of any of the  provisions  of its
Articles of Incorporation or Bylaws. The Company does not have any subsidiaries.
The Company does not directly or indirectly  own any equity or similar  interest
in, or any interest  convertible or exchangeable or exercisable  for, any equity
or similar  interest in, any  corporation,  partnership,  joint venture or other
business association or entity.

     2.2 Capital Structure.
         ------------------

     (a) The authorized  capital stock of the Company  consists of (i) 7,500,000
shares  of Common  Stock,  of which  there  were  3,592,145  shares  issued  and
outstanding as of the Execution  Date;  and (ii)  1,500,000  shares of Preferred
Stock,  none of which are currently  issued and  outstanding as of the Execution
Date. On the Execution  Date there are, and as of the Effective  Time there will
be,  no  outstanding   convertible  notes,   convertible   securities  or  other
commitments  to issue any shares of capital  stock or voting  securities,  other
than pursuant to the exercise of existing  Company  Options  previously  granted
under the Company  Stock Option  Plans,  in each case as  outstanding  as of the
Execution  Date, or as otherwise  specifically  allowed  pursuant to Section 4.1
hereof.

     (b) All outstanding  shares of Company  Capital Stock are duly  authorized,
validly  issued,  fully  paid  and  non-assessable  and are not  subject  to any
preemptive  rights  created  by  California  Law,  the  Company's   Articles  of
Incorporation or Bylaws,  or any agreement to which the Company is a party or by
which it is bound.  All outstanding  shares of Company Capital Stock were issued
in compliance in all material  respects  with all  applicable  federal and state
securities  laws. As of the  Execution  Date,  the Company has reserved  754,917
shares of Company Common Stock for issuance to employees pursuant to the Company
Stock Option Plans.  On the Execution  Date,  except for: (i) the rights created
pursuant to this  Agreement,  (ii) the Company  Stock Option Plans and (iii) the
Company's right to repurchase any unvested shares under the Company Stock Option
Plans or the stock  option  agreements  thereunder,  there are no, and as of the
Effective  Time,  there will be no,  other  options,  warrants,  calls,  rights,
commitments or agreements of any character to which the Company is a party or by
which it is bound obligating the Company to issue, deliver,  sell, repurchase or
redeem, or cause to be issued,  delivered,  sold,  repurchased or redeemed,  any
shares of Company  Capital  Stock or  obligating  the Company to grant,  extend,
accelerate the vesting of, change the price of, or otherwise amend or enter into
any such option, warrant, call, right, commitment or agreement, except as may be
permitted  under Section 4.1 hereof.  Except for the agreements  contemplated by
this Agreement,  there are no contracts,  commitments or agreements  relating to
voting,  purchase,  sale or ownership of Company  Capital Stock between or among
the Company and any of its security holders.

                                       9



     (c) Except as disclosed in Schedule 2.2(c),  the terms of the Company Stock
Option  Plans and the  Company  Options  permit the  assumption  of the  Company
Options by Parent as  provided  for in this  Agreement,  without  the consent or
approval of the holders of the Company Options, the Company's shareholders,  any
governmental  agency  which  may have  jurisdiction  under  California  Law,  or
otherwise,  without  any  acceleration  of  the  exercise  schedule  or  vesting
provisions  with respect to the Company  Options.  Schedule  2.2(c) sets forth a
list of all Company  Options,  warrants or other rights to acquire any shares of
Company  Capital Stock,  together with the holders  thereof,  exercise price and
term.  Except as set forth on Schedule 2.2(c),  none of the outstanding  Company
Options, nor any employment or consulting  agreements by and between the Company
and others permit any accelerated  vesting or  exercisability  of those options,
securities  or  notes,  as  applicable,  by  reason  of the  Merger or any other
transactions  contemplated  by this  Agreement.  True and complete copies of all
agreements and instruments  relating to or issued under the Company Stock Option
Plans,  the Company  Options or  otherwise  relating to the  issuance of Company
Options,  have been provided or made available to Parent and such agreements and
instruments  have not been amended,  modified or  supplemented,  and,  except as
otherwise  expressly  contemplated  herein,  there are no  agreements  to amend,
modify or supplement  such  agreements or instruments in any case from the forms
provided to Parent.

     2.3 Authority.
         ---------

     (a) The Company has all  requisite  corporate  power and authority to enter
into this Agreement and to consummate the transactions  contemplated hereby. The
execution  and  delivery  of  this  Agreement  and  the   consummation   of  the
transactions  contemplated  hereby have been duly  authorized  by all  necessary
corporate  action  on the  part  of the  Company,  other  than  approval  by the
Company's shareholders.

     (b) This  Agreement  has been duly  executed  and  delivered by Company and
constitutes the valid and binding obligation of the Company  enforceable against
the Company by Parent and Merger Sub in accordance with its terms. The execution
and delivery of this Agreement by the Company does not, and the execution of the
other  agreements  contemplated  by this Agreement and the  consummation  of the
transactions  contemplated  hereby and thereby will not, conflict with or result
in any violation of, or default under (with or without  notice or lapse of time,
or both), or give rise to a right of  termination,  cancellation or acceleration
of any  obligation  or loss of any  benefit  under:  (i)  any  provision  of the
Articles  of  Incorporation  or  Bylaws  of the  Company,  or (ii)  any  Company
Authorization (as defined in Section 2.8).

                                       10



     (c) No  consent,  approval,  order or  authorization  of, or  registration,
declaration  or filing with, any court,  administrative  agency or commission or
other governmental  authority or  instrumentality,  foreign,  federal,  state or
local (each, a "Governmental Entity") is required with respect to the Company in
connection with the execution and delivery of this Agreement or the consummation
of the  transactions  contemplated  hereby,  except  for (i) the  filings of the
Certificate of Merger,  together with the required  officers'  certificates,  as
provided  in Section  1.2,  (ii) the filing  with the  Securities  and  Exchange
Commission  (the  "SEC") and the Nasdaq  Stock  Market  ("Nasdaq")  of the Proxy
Statement  (as defined in Section  2.26)  relating  to the Company  Shareholders
Meeting (as defined in Section 2.26),  (iii) such consents,  approvals,  orders,
authorizations, registrations, declarations and filings as may be required under
applicable state securities laws and the securities laws of any foreign country,
(iv) the  filing  by Parent  and the  effectiveness  of a Form S-4  Registration
Statement with the SEC in accordance with the Securities Act of 1933, as amended
(the "Securities Act"), as amended,  (vi) the filing, if required,  of a current
report by Parent on Form 8-K with the SEC and AMEX in accordance  with the rules
and  regulations of the SEC; (vii) any notice  described in Section 5.16 hereof;
and  (viii)  such  other  consents,   authorizations,   filings,  approvals  and
registrations  which,  if not obtained or made,  would not  prevent,  materially
alter or delay any of the transactions contemplated by this Agreement.

     2.4 SEC Documents, Financial Statements.
         -----------------------------------

     (a) The Company has made  available to Parent a true and  complete  copy of
each statement,  report, registration statement (with the prospectus in the form
filed  pursuant  to  Rule  424(b)  of  the  Securities  Act),  definitive  proxy
statement,  and other filings filed with the SEC by the Company since January 1,
2000 (collectively,  the "Company SEC Documents"). The Company has not filed any
documents  with the SEC that are not  available  through  EDGAR since January 1,
2000. In addition, the Company has made available or provided to Parent complete
copies of all  exhibits  to the Company  SEC  Documents  filed prior to the date
hereof,  and  will  promptly  make  available  to  Parent  all  exhibits  to any
additional  Company  SEC  Documents  filed  prior  to the  Effective  Time.  All
documents  required to be filed as exhibits  to the Company SEC  Documents  have
been so filed. To the Company's knowledge,  as of their respective filing dates,
the  Company  SEC  Documents   complied  in  all  material   respects  with  the
requirements  of the Securities  Exchange Act of 1934, as amended (the "Exchange
Act"),  and the  Securities  Act and, to the  Company's  knowledge,  none of the
Company SEC Documents contained any untrue statement of material fact or omitted
to state a material fact required to be stated  therein or necessary to make the
statements made therein,  in light of the circumstances in which they were made,
not misleading, except to the extent corrected,  supplemented or superseded by a
subsequently filed Company SEC Document.

     (b) The financial  statements of the Company,  including the notes thereto,
included in the Company SEC Documents (the "Company  Financial  Statements") and
the unaudited balance sheet of the Company,  dated as of September 30, 2002 (the
"Company  Balance  Sheet  Date"),  were  complete  and  correct in all  material
respects  as of their  respective  dates,  complied  as to form in all  material
respects with applicable  accounting  requirements  and with the published rules
and  regulations of the SEC with respect thereto as of their  respective  dates,
and have been prepared in accordance  with U.S.  generally  accepted  accounting
principles  ("GAAP")  applied  on a  basis  consistent  throughout  the  periods
indicated  and  consistent  with each other  (except as may be  indicated in the
notes  thereto or, in the case of  unaudited  statements,  included in Quarterly
Reports on Form 10-QSB,  as  permitted  by Form 10-QSB of the SEC).  The Company
Financial  Statements  fairly present in all material  respects the consolidated
financial condition and operating results of the Company as of the dates and for
the periods indicated therein (subject, in the case of unaudited statements,  to
normal,   recurring   year-end   adjustments).   There  have  been  no  material

                                       11



disagreements between the Company and its auditors with respect to the treatment
and or characterization of items contained in the Company Financial Statements.

     (c) The Company has fully complied with all certification requirements, and
will comply with all  certification  requirements  prior to the Effective  Time,
under the Sarbanes-Oxley Act of 2002.

     2.5 Absence of Certain  Changes.  Except as expressly  contemplated by this
         ---------------------------
Agreement,  since the Company  Balance  Sheet Date there has not occurred and on
the Closing  Date there will not have  occurred  (except as permitted by Section
4.1  hereof):  (i) any  change,  event or  condition  (whether or not covered by
insurance or similar  indemnification  agreement) that has resulted in, or would
reasonably be expected to result in, a Company Material Adverse Effect, (ii) any
acquisition,  sale or transfer of any material  asset of the Company,  (iii) any
change in accounting methods or practices  (including any change in depreciation
or  amortization  policies  or rates) by the Company or any  revaluation  by the
Company of any of its material assets,  (iv) any declaration,  setting aside, or
payment of a dividend or other  distribution  with respect to the shares Company
Capital  Stock,  or  any  direct  or  indirect  redemption,  purchase  or  other
acquisition by the Company of any of the shares of Company  Capital  Stock,  (v)
any action to amend or change the  Articles  of  Incorporation  or Bylaws of the
Company (nor will there be prior to the Effective Time), or (vi) any negotiation
or agreement by the Company to do any of the things  described in the  preceding
clauses  (i)  through  (v)  (other  than   negotiations   with  Parent  and  its
representatives regarding the transactions contemplated by this Agreement).

     2.6  Absence of  Undisclosed  Liabilities.  Except as set forth on Schedule
          ------------------------------------
2.6,  the Company  has no  material  obligations  or  liabilities  of any nature
(matured or unmatured,  fixed or contingent)  other than: (i) those set forth or
adequately reflected or reserved against on the balance sheet or in the notes to
the Company  Financial  Statements  for the period ended on the Company  Balance
Sheet Date,  (ii) those  incurred in the ordinary  course of business  since the
Company  Balance Sheet Date,  and (iii) those  incurred in  connection  with the
execution of this Agreement.

     2.7 Litigation.  As of the Execution Date,  except as set forth on Schedule
         ----------
2.7,  there is no private  or  governmental  action,  suit,  proceeding,  claim,
arbitration,  governmental investigation, or to the knowledge of the Company any
private investigation,  pending before any agency, court or tribunal, foreign or
domestic  (each a  "Proceeding"),  or, to the  knowledge of Company,  threatened
against the Company or any of its respective properties or any of its respective
officers or  directors  (in their  capacities  as such).  There is no  judgment,
decree or order against the Company, or, to the knowledge of the Company, any of
its respective  directors or officers (in their capacities as such),  that seeks
to  prevent,  enjoin,  or  materially  alter  or delay  any of the  transactions
contemplated by this Agreement,  or that could  reasonably be expected to have a
Company Material  Adverse Effect.  Notwithstanding  the foregoing,  no judgment,
decree or order  arising  from or relating to any  proceeding  disclosed  in the
Company  Disclosure  Schedule or the Company  SEC  Documents  shall be deemed to
constitute or give rise to any breach of this Section 2.7.

                                       12



     2.8  Governmental  Authorization.  The Company has obtained  each  federal,
          ---------------------------
state, county, local or foreign governmental consent, license, permit, grant, or
other authorization of a Governmental  Entity: (i) pursuant to which the Company
currently operates or holds any interest in any of its properties (including the
Properties or the  Facilities) or (ii) that is required for the operation of the
Company's  business  or the  holding of any such  interest  ((i) and (ii) herein
collectively  called  the  "Company  Authorizations"),  and  all of the  Company
Authorizations are in full force and effect,  except where the failure to obtain
or have any  Company  Authorization  does not have a  Company  Material  Adverse
Effect.

     2.9 Title to Personal  Property.  Except as indicated on Schedule  2.9, the
         ---------------------------
Company has good, valid and marketable  title to all of its respective  personal
properties,  interests in personal  properties and material  assets that it owns
and that are  reflected  in the  Company  Balance  Sheet or  acquired  after the
Company  Balance Sheet Date,  which  properties  and assets with a book value of
$10,000 or above are listed on Schedule  2.9 (except  properties,  interests  in
properties  and assets sold or otherwise  disposed of since the Company  Balance
Sheet  Date in the  ordinary  course of  business),  or with  respect  to leased
properties  and  assets,  valid  leasehold  interests,  free  and  clear  of all
mortgages,  liens,  pledges,  charges or  encumbrances of any kind or character,
except:  (i) a lien  for  current  taxes  not  yet due and  payable,  (ii)  such
imperfections  of title,  liens and easements as do not and will not  materially
detract  from or interfere  with the use of the  properties  subject  thereto or
affected thereby, or otherwise  materially impair business operations  involving
such  properties,  (iii) liens  securing debt which are reflected on the Company
Balance  Sheet,  and (iv) liens that in the  aggregate  would not have a Company
Material Adverse Effect. To the Company's  knowledge,  the plants,  property and
equipment of the Company that are used in the  operations of its business are in
good  operating  condition  and  repair,  subject to normal  wear and tear.  All
personal  properties  used in the operations of the Company are reflected in the
Company Balance Sheet to the extent GAAP requires the same to be reflected.

     2.10 Environmental Matters.
          ---------------------

     (a) The following terms shall be defined as follows:

          (i) "Environmental Law" shall mean any statute,  law (including common
               -----------------
law),  treaty,  ordinance,  rule,  regulation,  code,  license, permit, consent,
approval,  judgment,  order,  administrative   order   or  decision,  decree  or
injunction  of  any  Governmental  Entity  relating  to  the protection of human
health  or   the   environment  (including   air,   water,  soil   and   natural
resources),  or  the  generation,   treatment,   manufacturing,   use,  storage,
handling, recycling, presence, release, disposal, transportation or  shipment of
any Hazardous Material.


          (ii)  "Facilities"  shall mean all buildings and  improvements  on the
                 ----------
Property.

          (iii) "Hazardous Material" shall mean any material,  substance, waste,
                 ------------------
pollutant  or   contaminant   listed,  defined,  designated   or  classified  as
hazardous,  toxic,  flammable,   explosive,  reactive,  corrosive,   infectious,
carcinogenic,   mutagenic   or  radioactive  or  otherwise   regulated   by  any
Governmental  Entity  or  under  any  Environmental  Law, including petroleum or
petroleum  products  (including  crude  oil) and  any  derivative or by-products

                                       13



thereof,  natural  gas,  synthetic  gas  and  any  mixtures   thereof,   or  any
substance  that  is or  contains polychlorinated  biphenyls (PCB's),  radon gas,
urea formaldehyde, asbestos-containing materials (ACM) or lead.


          (iv)  "Property"  shall mean all real property  leased or owned by the
                 --------
Company  either  currently  or  in  the  past,  including  the Real Property (as
defined  in  Section  2.24(a)) and  the  Leased  Premises (as defined in Section
2.24(f)).

          (v) "Release" shall mean any releasing,  spilling,  leaking,  pumping,
               -------
pouring,  placing,  emitting,   emptying,   discharging,  injecting,   escaping,
leaching,  disposing,  or  dumping  into  the  environment,  whether intentional
or   unintentional,   negligent   or   non-negligent,  sudden   or   non-sudden,
accidental or non-accidental.

     (b) The Company represents and warrants as follows:

          (i) The  operations  of the Company  have at all times been and are in
compliance  with  all  Environmental  Laws,  except   where  any   noncompliance
would not have a Company Material Adverse Effect.

          (ii) The  Company  has  obtained   and  is  in  full  compliance  with
all  permits,   licenses,    authorizations   and   approvals   required   under
Environmental  Law  with  respect  to  the  operation or conduct of its business
or  the  ownership  or   operation  of  its   properties  and   facilities  (the
"Environmental  Approvals"),  each  such  Environmental   Approval  is  in  full
force  and  effect,  and  each  such Environmental  Approval will remain in full
force  and  effect  after  the  execution,  delivery  and  performance  of  this
Agreement,  provided  that  any  transfer  documents  required  by Environmental
Law  for  such  Environmental  Approval  and identified  on Schedule 2.10(b)(ii)
are completed as required by Environmental Law.

          (iii) Neither Company nor any of its Property or Facilities is subject
to  any  Order (as  defined  in  Section  5.6(b)) or  proposed  Order  under any
Environmental  Law.  The Company  has  not  received  any notice from any person
or  Governmental   Entity   regarding   or   alleging,   and   no  condition  or
circumstance  exists  that  is  reasonably likely  to result in (with or without
notice  or  lapse  of  time or both)  a violation  or failure to comply with any
term or requirement of any Environmental Law or Environmental Approval.

          (iv) The  Company  has  provided  or made  available  to Parent  true,
complete   and  correct   copies   and   results  of   all   studies,   reports,
assessments,   surveys,   correspondence,   investigations,   audits,  analysis,
tests  and  other  documents  (whether in  hard  copy or electronic form) in the
Company's   or  their  counsel's  possession   or  control  pertaining   to  the
presence  or  alleged  presence  of any Hazardous  Material  at, on or affecting
any  Property  or  Facilities,  or regarding  the  Company's compliance with any
applicable Environmental Law or Environmental Approval.


          (v) To the Company's  knowledge,  none of the following  exists at any
Property  or  Facilities: any  asbestos-containing  material  in  any form which
is  friable;  urea  formaldehyde  foam  insulation;  polychlorinated  biphenyls;
active  or  out-of-service  or  underground  storage  tanks  or sites from which

                                       14



such  storage  tanks  have  been  removed; or landfills,  surface  impoundments,
waste piles or land disposal areas.


          (vi) To the  Company's  knowledge,  the  Company is not a  potentially
responsible  party  under  the  federal  Comprehensive  Environmental  Response,
Compensation  and  Liability  Act (CERCLA),  or  state  analog statute,  arising
out of events occurring prior to the Closing Date.

     2.11 Taxes.
          -----

     (a) The Company has timely filed all Tax Returns (as defined below) that it
was required to file, and such Tax Returns are true, correct and complete in all
material respects.  All Taxes (as defined below) shown to be payable on such Tax
Returns or on subsequent assessments with respect thereto have been paid in full
on a timely basis, and no other Taxes are payable by the Company with respect to
any  period  ending  prior to the  Execution  Date,  whether or not shown due or
reportable  on such Tax Returns,  other than Taxes for which  adequate  accruals
have been provided in the Company  Financial  Statements or amounts payable with
respect to periods or portions of periods after the Company  Balance Sheet Date.
The Company has withheld and paid over all Taxes  required to have been withheld
and  paid  over,  and  complied  with  all  information   reporting  and  backup
withholding requirements, including maintenance of required records with respect
thereto.  The Company  does not have any  material  liability  for unpaid  Taxes
accruing after the Company Balance Sheet Date,  except for Taxes incurred in the
ordinary  course of business.  There are no liens for Taxes on the properties of
the Company, other than liens for Taxes not yet due and payable.

     (b) Except as disclosed in the Schedule 2.11(b),  no Tax Returns of Company
have been audited. The Company has delivered or made available to Parent correct
and  complete  copies  of  all  Tax  Returns  filed,  examination  reports,  and
statements  of  deficiencies  assessed or agreed to by Company for the last five
years.  Except as  disclosed  in  Schedule  2.11(b),  Company has not waived any
statute of  limitations  in respect of any Tax or agreed to an extension of time
with respect to any Tax assessment or deficiency.

     (c) The Company is not a party to or bound by any tax indemnity  agreement,
tax sharing  agreement  or similar  contract.  The Company is not a party to any
joint venture,  partnership,  or other  arrangement or contract,  which could be
treated as a  partnership  or  "disregarded  entity" for United  States  federal
income tax purposes.

                                       15



     (d)  The  Company  is  not  obligated  under  any  agreement,  contract  or
arrangement  that may  result in the  payment  of any  amount  that would not be
deductible by reason of Sections 162(m) or 280G of the Code.

     (e) The  Company  has not been or, to its  knowledge,  will be  required to
include any material adjustment in Taxable income for any Tax period (or portion
thereof) pursuant to Section 481 or 263A of the Code or any comparable provision
under  state  or  foreign  Tax  laws as a  result  of  transactions,  events  or
accounting  methods employed prior to the Merger other than any such adjustments
required as a result of the  Merger.  The Company has not filed or will file any
consent to have the  provisions of paragraph  341(f) of the Code (or  comparable
provisions  of any state Tax laws)  apply to the  Company.  The  Company has not
filed any  disclosures  under  Section 6662 or  comparable  provisions of state,
local or foreign law to prevent the  imposition of penalties with respect to any
Tax reporting position taken on any Tax Return. The Company is not currently nor
has it been a United  States  real  property  holding  corporation  (within  the
meaning  of  Section  897(c)(2)  of the  Code)  during  the  applicable  periods
specified in Section 897(c)(1)(A)(ii) of the Code.

     (f) The Company  has not been the  "distributing  corporation"  (within the
meaning  of  Section  355(c)(2)  of the  Code)  with  respect  to a  transaction
described in Section 355 of the Code within the three (3) year period  ending as
of the date of this Agreement.

     (g) For purposes of this Agreement,  the following terms have the following
meanings: "Tax" (and, with correlative meaning, "Taxes" and "Taxable") means (i)
any net income, alternative or add-on minimum tax, gross income, gross receipts,
sales, use, ad valorem,  transfer,  franchise,  profits,  license,  withholding,
payroll,  employment,  excise, severance, stamp, occupation,  premium, property,
environmental  or windfall profit tax, custom,  duty or other tax,  governmental
fee or other like assessment or charge of any kind whatsoever, together with any
interest or any penalty,  addition to tax or  additional  amount  imposed by any
Governmental  Entity (a "Tax  Authority")  responsible for the imposition of any
such tax  (domestic  or  foreign),  (ii) any  liability  for the  payment of any
amounts  of the  type  described  in (i) as a result  of  being a  member  of an
affiliated,  consolidated, combined or unitary group for any Taxable period, and
(iii) any liability for the payment of any amounts of the type  described in (i)
or (ii) as a result of being a transferee of or successor to any Person, or as a
result of any express or implied  obligation to indemnify  any other Person.  As
used  herein,  "Tax  Return"  shall mean any return,  statement,  report or form
(including,  without limitation,  estimated tax returns and reports, withholding
tax  returns and reports and  information  reports and  returns)  required to be
filed with respect to Taxes.

     2.12 Employee Benefit Plans.
          ----------------------

     (a) The following terms shall be defined as follows:

          (i)  "Defined  Benefit  Plan"  shall mean either a plan  described  in
                ----------------------
Section  3(35)  of  ERISA  or a  plan subject to the minimum  funding  standards
set forth in Section 302 of ERISA and Section 412 of the Code.

                                       16



          (ii) "ERISA" shall mean the Employee Retirement Income Security Act of
                -----
1974, as amended.

          (iii)  "Member  of the  Controlled  Group"  shall  mean each  trade or
                  ---------------------------------
business,  whether  or  not  incorporated,  that  would  be  treated as a single
employer  with  Company  under  Section  4001 of ERISA or  Section  414(b), (c),
(m) or (o) of the Code.

          (iv) "Multiemployer Plan" shall mean a plan described in Section 3(37)
                ------------------
of ERISA.

     (b) Schedule 2.12(b) lists (i) all material "employee benefit plans" within
the meaning of Section 3(3) of ERISA, (ii) all individual employment agreements,
and (iii) all other bonus or other incentive  compensation,  stock option, stock
purchase,  stock  appreciation,  severance  pay,  lay-off or reduction in force,
change in  control,  sick  pay,  vacation  pay,  salary  continuation,  leave of
absence,  educational  assistance,  service  award,  employee  discount,  fringe
benefit  plans,   arrangements  or  policies,   which  Company  maintains  or  ,
contributes to, (collectively, the "Plans").

     (c) None of the Plans is a Defined  Benefit  Plan,  and neither the Company
nor any  Member  of the  Controlled  Group  has ever  sponsored,  maintained  or
contributed to, or ever been obligated to contribute to, a Defined Benefit Plan.

     (d) None of the Plans is a Multiemployer  Plan, and neither the Company nor
any  Member  of the  Controlled  Group  has ever  contributed  to,  or ever been
obligated to contribute to, a Multiemployer Plan.

     (e) The Company does not maintain or  contribute  to any plan that provides
health benefits to an employee after the employee's termination of employment or
retirement  except as required  under Section 4980B of the Code and Sections 601
through 608 of ERISA.

     (f) Each Plan which is an  "employee  benefit  plan," as defined in Section
3(3) of ERISA,  complies in all material  respects by its terms and in operation
with the Code and ERISA  requirements  currently in effect and applicable to the
Plan.

     (g) Each of the Plans that is intended to qualify under  Section  401(a) of
the Code has been determined by the Internal Revenue Service so to qualify after
January 1, 1989, and each trust maintained  pursuant thereto has been determined
by the Internal  Revenue Service to be exempt from taxation under Section 501 of
the Code.  To the knowledge of Company,  nothing has occurred  since the date of
the  Internal  Revenue  Service's  favorable  determination  letter  that  could
adversely affect the qualification of the Plan and its related trust

     (h) All  contributions  required to be made pursuant to the terms of a Plan
prior to the Closing Date  (including  periods from the first day of the current
plan year to the  Closing  Date)  have been made  prior to the  Closing  Date by
Company or have been reserved against on the Company Financial Statements.

                                       17



     (i)  With  respect  to  each  Plan:  (i) to  the  Company's  knowledge,  no
prohibited  transactions  (as  defined in Section 406 or 407 of ERISA or Section
4975  of the  Code)  have  occurred  for  which  a  statutory  exemption  is not
available; (ii) no action or claims (other than routine claims for benefits made
in the  ordinary  course of Plan  administration  for which Plan  administrative
review  procedures have not been exhausted) are pending,  or to the knowledge of
the Company, threatened or imminent against or with respect to the Plan,

     (j) True,  correct and complete copies of all Plan documents have been made
available to Parent, and true, correct and complete copies of the last two years
Forms 5500 for each Plan  required to make such filing have been made  available
to Parent.

     2.13 Certain Agreements  Affected by the Merger.  Neither the execution and
          ------------------------------------------
delivery of this Agreement nor the consummation of the transactions contemplated
hereby will (i) result in any material payment  (including,  without limitation,
any severance,  unemployment  compensation,  golden  parachute or bonus payment)
becoming due to any director,  officer,  agent or employee of the Company or any
other third party,  (ii) materially  increase any benefits  otherwise payable by
the Company to its employees or (iii) result in the  acceleration of the time of
payment or vesting of any such benefits.























                                       18




     2.14 Employee Matters.
          ----------------

     (a) The Company is in  compliance  with all currently  applicable  laws and
regulations  respecting  employment,  discrimination  in  employment,  terms and
conditions of employment,  wages,  hours and occupational  safety and health and
employment practices,  and are not engaged in any unfair labor practice,  except
where  the  failure  to be in  compliance  or the  engagement  in  unfair  labor
practices  has not had and would not be  reasonably  expected  to have a Company
Material Adverse Effect.  The Company has in all material  respects withheld all
amounts required by law or by agreement to be withheld from the wages, salaries,
and other  payments to their  respective  employees;  and are not liable for any
arrears of wages or any taxes or any  penalty  for failure to comply with any of
the foregoing.

     (b) To the Company's  knowledge,  the Company is not liable for any payment
to any  trust or other  fund or to any  Governmental  Entity,  with  respect  to
unemployment  compensation  benefits,  social  security  or  other  benefits  or
obligations for employees  (other than routine payments to be made in the normal
course of business  and  consistent  with past  practice).  There are no pending
claims against the Company under any workers' compensation plan or policy or for
long term  disability  that are not covered by  insurance.  The Company does not
have any  obligations  under  COBRA  with  respect to any  former  employees  or
qualifying  beneficiaries  thereunder,  except obligations that would not have a
Company Material Adverse Effect.  There are no controversies  pending or, to the
knowledge  of the  Company,  threatened,  between  the  Company  and  any of its
employees, which controversies have or could reasonably be expected to result in
a Proceeding against the Company before any Governmental  Entity except for such
Proceedings that would not have a Company  Material Adverse Effect.  The Company
is not a party to any  collective  bargaining  agreement  or other  labor  union
contract,  nor does the Company know of any  activities  or  proceedings  of any
labor union or organization of any such employees.

     (c) To  the  Company's  knowledge,  no  employees  of  the  Company  are in
violation of any term of any employment contract,  patent disclosure  agreement,
enforceable  non-competition  agreement, or any enforceable restrictive covenant
to a former  employer  relating to the right of any such employee to be employed
by the Company  because of the nature of the  business  conducted  or  presently
proposed  to be  conducted  by the  Company  or to the use of trade  secrets  or
proprietary  information of others. None of the key employees listed on Schedule
2.14(c) have given written notice to the Company,  nor is the Company  otherwise
aware that any such employee intends to terminate his or her employment with the
Company.

     2.15  Insurance.  The Company  has made  available  to Parent all  material
           ---------
policies of insurance as set forth on Schedule 2.15.  There is no material claim
pending  under  any of such  policies  or bonds as to  which  coverage  has been
questioned,  denied or disputed by the  underwriters  of such policies or bonds.
All  premiums due and payable  under all such  policies and bonds have been paid
and the Company is otherwise in  compliance  with the terms of such policies and
bonds. The Company does not have knowledge of any threatened  termination of, or
material premium increase with respect to, any of such policies.

                                       19



     2.16  Compliance  With Laws.  The  Company  has  complied  with,  is not in
           ---------------------
violation of, and has not received any notices of violation  with respect to any
federal,  state, local or foreign statute, law or regulation with respect to the
conduct of its business,  or the ownership or operation of its business,  except
for such violations or failures to comply that would not have a Company Material
Adverse Effect.

     2.17  Brokers'  and Finders'  Fees.  Except for the $100,000 fee payable to
           ----------------------------
T.R. Winston & Company,  Inc., the Company has not incurred,  nor will it incur,
directly or indirectly,  any liability for brokerage or finders' fees or agents'
commissions  or investment  bankers'  fees or any similar  charges in connection
with this Agreement, the Merger or any other transaction contemplated hereby.

     2.18 Vote Required.  The  affirmative  vote of the holders of a majority of
          -------------
the shares of Company  Common Stock  outstanding  on the record date set for the
Company  Shareholders  Meeting  is the only  vote of the  holders  of any of the
Company Capital Stock  necessary to approve this Agreement and the  transactions
contemplated hereby.

     2.19  Board  Approval.  The Board of  Directors  of the  Company  has:  (i)
           ---------------
reviewed,   deliberated  and  approved  this  Agreement  and  the  Merger,  (ii)
determined that there are no other proposed extraordinary  transactions with the
Company on terms more  advantageous to the  shareholders  of the Company,  (iii)
that the Merger is in the best interests of the  shareholders of the Company and
is on terms that are fair to such  shareholders,  and (iv) resolved to recommend
that the shareholders of the Company approve this Agreement and the Merger.

     2.20 Customers and Suppliers. Schedule 2.20 lists the top ten customers and
          -----------------------
top ten suppliers of the Company in terms of gross revenues and gross purchases,
respectively,  during the twenty four (24) months prior to the  Execution  Date;
and no such  customer  and no such  supplier  of the  Company  has  canceled  or
otherwise  terminated  or made any  written  threat  to  Company  to  cancel  or
otherwise  terminate its relationship  with Company,  or at any time on or after
the  Company  Balance  Sheet Date has  materially  decreased  its  purchases  or
supplies to the Company,  in the case of any such supplier,  or its usage of the
services or products of the Company,  in the case of such  customer,  and to the
Company's knowledge, no such supplier or customer intends to cancel or otherwise
terminate  its  relationship  with the  Company or to  decrease  materially  its
services or supplies to the Company or its usage of the  services or products of
the  Company,  as the case may be. The Company has not  knowingly  breached  any
agreement  with,  or engaged in any  fraudulent  conduct  with  respect  to, any
customer or supplier of the Company.

     2.21  Material  Contracts.  Except:  (i) for the  contracts  filed with the
           -------------------
Company SEC Documents pursuant to Item 601 of Regulation S-B under the rules and
regulations of the SEC; (ii) as set forth in Schedule 2.21 (the contracts in (i)
and (ii) being collectively referred to herein as the "Material Contracts"); and
(iii) for this Agreement,  and other contracts and agreements which individually
or in the  aggregate  are not material to the  Company's  businesses,  as of the
Execution Date, the Company is not a party to or bound by:

                                       20



     (a) any distribution agreement,  manufacturer's  representative  agreement,
partnership agreement or joint R&D or technology sharing arrangements;

     (b) any  continuing  contract  for  the  purchase  or  sale  of  materials,
supplies,  equipment or services, or any agency or indemnification  arrangement,
involving  in the case of any such  contract  more than $50,000 over the life of
the contract;

     (c) any trust indenture, mortgage, promissory note, loan agreement or other
contract for borrowed money not reflected in the Company  Financial  Statements,
any currency exchange,  commodities or other hedging  arrangement or any leasing
transaction  involving  in  excess of  $50,000  and of the type  required  to be
capitalized in accordance with GAAP;

     (d) any contract for capital  expenditures or royalty payments in excess of
$50,000 in the aggregate;

     (e) any  contract  limiting the freedom of Company to engage in any line of
business,  to acquire  any product or asset from any other  Person,  to sell any
product or asset to, or to perform any service  for,  any Person,  or to compete
with any other Person (as that term is defined in the Exchange Act);

     (f)  any  confidentiality,   secrecy  or  nondisclosure   contract,   which
individually or in the aggregate,  materially affects the business or operations
of the Company;

     (g) any contract  pursuant to which Company is a lessor of real property or
any machinery,  equipment,  motor vehicles, office furniture,  fixtures or other
personal  property  involving in the case of any such personal  property contact
more than $50,000 over the life of the contract;

     (h) any  contract  with any Person that would be  required to be  disclosed
under Item 404 of Regulation S-B under the rules and regulations of the SEC;

     (i) any contract  which  provides for the  indemnification  of any officer,
director, employee or agent; or

     (j) any agreement of guarantee,  support,  assumption or endorsement of, or
any similar  commitment with respect to, the obligations,  liabilities  (whether
accrued, absolute,  contingent or otherwise) or indebtedness of any other Person
not reflected in the Company Financial Statements.

     2.22 No Breach of Material  Contracts.  All Material  Contracts  are in the
          --------------------------------
written  form  previously  provided  or made  available  to  Parent.  Except  as
disclosed  in  Schedule  2.22,  the Company has  performed  all of the  material
obligations required to be performed by it as of the date hereof and is entitled
to all benefits under, and, to the Company's knowledge,  is not alleged to be in
material  breach or default in respect  of any  Material  Contract.  Each of the
Material  Contracts  is in full force and effect  with  respect to the  Company,
unamended  except as  provided  or made  available  to  Parent,  and,  except as

                                       21



disclosed  in  Schedule  2.22,  there  exists no  default or event of default or
event,  occurrence,  condition  or act,  with  respect to the Company or, to the
Company's  knowledge,  with respect to the other contracting party,  which, with
the giving of notice,  the lapse of the time or the happening of any other event
or  conditions,  would  become a default or event of default  under any Material
Contract or would give any Person the right to exercise any remedy, or the right
to any rebate, chargeback, penalty or change in delivery schedule, except to the
extent such defaults,  remedies, penalties or changes have not had and would not
be reasonably expected to have a Company Material Adverse Effect.

     2.23  Material  Third  Party  Consents.  Schedule  2.23 lists all  Material
           --------------------------------
Contracts that require a novation or consent to the Merger or change of control,
as the case may be,  prior to the  Effective  Time so that  such  contracts  may
remain in full  force and  effect  after the  Closing  (the  "Company  Contracts
Requiring Novation or Consent") which, if no novation occurs or if no consent to
the  Merger or change of  control is  obtained,  would  have a Material  Adverse
Effect on Parent's  ability to operate the  business in  substantially  the same
manner as the business was operated by the Company prior to the Effective Time.

     2.24 Real Property and Real Property Leases.
          --------------------------------------

     (a) The Company does not own any real property.

     (b)  Schedule  2.24(b)  sets forth a list of all leases,  licenses or other
occupancy  agreements to which the Company is a party,  for the use or occupancy
of  real  estate  owned  by a third  party  ("Leases")  (copies  of  which  have
previously  been  furnished to Parent),  in each case,  setting  forth:  (i) the
lessor and lessee  thereof and the  commencement  date,  term and renewal rights
under each of the Leases,  and (ii) the street  address or legal  description of
each property  covered thereby (the "Leased  Premises").  The Leases are in full
force and effect,  and to the  knowledge of the  Company,  have not been amended
except as disclosed in said Schedule 2.24(b), and the Company is not and, to the
knowledge of the Company,  no other party thereto, is in default or breach under
any such Lease and no event has occurred by the Company  that,  with the passage
of time or the giving of notice or both,  would  cause a breach of or default of
the Company  under any of such Leases,  except to the extent such default  would
not have a Company  Material  Adverse  Effect.  Except as  disclosed in Schedule
2.24(b),  the  Company  has  valid  leasehold  interests  in each of the  Leased
Premises, which leasehold interest is free and clear of any liens, covenants and
easements  or title  defects of any nature  whatsoever,  except the  matters set
forth on Schedule 2.24(b),  or those that do not materially and adversely affect
the current use of the property.

     (c) With  respect  to the  Leased  Premises,  and  except  as set  forth on
Schedule 2.24(c),

          (i)  there  are no  pending  or,  to  the  knowledge  of the  Company,
threatened   condemnation   proceedings,   suits   or   administrative   actions
relating   to  any  such  parcel  or other  matters  affecting  materially   and
adversely the current use, occupancy or value thereof,

                                       22



     (ii) to the  knowledge  of the Company,  all  improvements,  buildings  and
systems  on any such  parcel  are in good  repair  and safe  for  their  current
occupancy and use,

     (iii) to the knowledge of the Company, there are no contracts or agreements
(whether  oral or written)  granting to any party or parties the right of use or
occupancy of any such parcel,  and there are no parties (other than the Company)
in possession of any such parcel,

     (iv) to the knowledge of the Company,  there are no outstanding  options or
rights of first  refusal or similar  rights to  purchase  any such parcel or any
portion thereof or interest therein,

     (v) to the knowledge of the Company,  all  Facilities  located on each such
parcel are  supplied  with  utilities  and other  services  necessary  for their
ownership,  operation or use, currently or as currently proposed by the Company,
all of which  services  are adequate in  accordance  with all  applicable  laws,
ordinances, rules and regulations, and

     (vi) to the  knowledge  of the  Company,  each such parcel abuts on and has
adequate direct vehicular access to a public road and there is no pending or, to
the knowledge of the Company, threatened termination of such access.

     2.25  Registration  Statement;   Proxy  Statement/Proxy.   The  information
           -------------------------------------------------
relating  to the  Company  which  is  provided  by the  Company  (including  any
information previously provided by the Company in the Company SEC Documents) for
inclusion  in the  Parent's  registration  statement  on Form S-4 (or such other
successor  form as may be  appropriate)  pursuant  to which the shares of Parent
Common  Stock  to be  issued  in the  Merger  will be  registered  with the SEC,
including any amendments or supplements  thereto (the "Registration  Statement")
shall not, at the time the Registration Statement is declared "effective" by the
SEC,  contain  any  untrue  statement  of a  material  fact or omit to state any
material  fact  required to be stated  therein or necessary in order to make the
statements  therein,  in light of the circumstances  under which they were made,
not misleading. The information relating to the Company which is provided by the
Company  (including any  information  previously  provided by the Company in the
Company SEC  Documents)  for inclusion in the proxy  statement/prospectus  to be
sent to the  shareholders  of the Company in connection  with the meeting of the
Company's shareholders (the "Company Shareholders Meeting") and the shareholders
of the Parent in  connection  with the  meeting of  Parent's  shareholders  (the
"Parent  Shareholders  Meeting"),  as may be amended or supplemented (the "Proxy
Statement")  shall  not,  on the date  the  Proxy  Statement  is  mailed  to the
shareholders of the Company and Parent, at the time of the Company  Shareholders
Meeting,  the Parent Shareholders Meeting and at the Effective Time, contain any
untrue  statement of a material fact or omit to state any material fact required
to be stated  therein or necessary in order to make the statements  therein,  in
light of the circumstances  under which they were made, not misleading;  or omit
to state a material  fact  necessary  to  correct  any  statement  in an earlier
communication  with  respect  to the  solicitation  of proxies  for the  Company
Shareholders  Meeting or Parent  Shareholders  Meeting which has become false or
misleading.  Notwithstanding the foregoing, the Company makes no representation,
warranty  or covenant  with  respect to any  information  supplied by Parent and

                                       23



relating to Parent,  which is  contained  in the  Registration  Statement or the
Proxy Statement.

     2.26 Tax Matters. To the Company's knowledge neither the Company nor any of
          -----------
its affiliates has taken or agreed to take any action, nor does the Company have
knowledge  of any fact or  circumstance,  that would  prevent  the  Merger  from
qualifying as a reorganization within the meaning of Section 368(a) of the Code.

     2.27 Opinion of Financial Advisor. The Company will not engage the services
          ----------------------------
of a financial advisor for a fairness opinion.

     2.28 Takeover  Statutes.  No "fair  price,"  "moratorium,"  "control  share
          ------------------
acquisition" or other similar  anti-takeover statute under California Law (each,
a "Takeover  Statute") is applicable to the Merger,  except for such statutes or
regulations as to which all necessary  actions have been or will be taken by the
Company and its Board of Directors to permit the  consummation  of the Merger in
accordance with the terms hereof.

     2.29 FDA Matters.
          -----------

     (a)  The  Company  has  all  licenses,   permits,   consents,   privileges,
authorizations,  immunities  and  orders  of the Food  and  Drug  Administration
("FDA") required for conducting  business as currently  conducted by the Company
at the Company's  facilities.  To the Company's  knowledge,  the Company has not
received  written  notice of any  action  pending  or  threatened  by the FDA to
revoke,  restrict,  withdraw or suspend any such  licenses,  permits,  consents,
privileges, authorizations, immunities or orders.

     (b) The Company's  facility is registered  with the FDA as a medical device
manufacturer  with its own  authority to conduct  business,  including,  but not
limited to,  possessing an  owner/operator  number (#2021836) issued by the FDA.
The Company's  FDA  authorizations  at the  Company's  facility will continue in
effect and the  Company  can  continue  to operate  independently  under the FDA
registration and all other authorizations after the effectiveness of the Merger.

     (c) The Company's  operations  have been conducted so as to comply,  in all
material respects,  with all applicable binding  administrative  policies of the
FDA and any other governmental body relating to the research and development and
manufacture of medical devices under development at the Company's facility.  All
outstanding  audit  issues from the FDA,  including,  but not limited to,  those
listed on FDA Form 483 have been  answered and resolved to the  satisfaction  of
the FDA.

     (d) The Company's facility is currently  certified for the areas of design,
development,   production  and   distribution   of  medical  devices  under  the
requirements of the  International  Standards  Organization  ("ISO") 9001 and EN
46001. To the Company's knowledge,  all outstanding  questions or issues derived
from  prior  audits and  inspections  by TUV,  relating  to ISO 9001 or EN 46001
certification,  have been rectified  and/or  corrected or the corrective  action
required to correct the  outstanding  issues  remaining  will not have a Company

                                       24



Material  Adverse  Effect.  To the  Company's  knowledge,  the  Company  has not
received  written  notice of any  action  pending  or  threatened  by the ISO to
revoke, restrict, withdraw or suspend any such ISO certification.

     2.30  Investigation  by  Company;   Parent's  Liability.  The  Company  has
           -------------------------------------------------
conducted  its  own  independent  investigation,  review  and  analysis  of  the
business,  operations,  assets,  liabilities,  results of operations,  financial
condition,  software,  technology and prospects of Parent,  which investigation,
review and  analysis  was done by the  Company  and,  to the extent the  Company
deemed appropriate,  by the Company's representatives.  The Company acknowledges
that it and its  representatives  have  been  provided  adequate  access  to the
personnel,  properties,  premises  and  records  of  Parent as the  Company  has
requested  for such  purpose.  In  entering  into this  Agreement,  the  Company
acknowledges  that it has relied solely upon the  aforementioned  investigation,
review and  analysis  and not on any  factual  representations  or  opinions  of
Parent's or any of Parent's representatives, except the specific representations
and  warranties  of the  Parent  set  forth  in this  Agreement  and the  Parent
Disclosure  Schedule.  The Company has formed an independent judgment concerning
Parent.

                                   ARTICLE III

             REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

     In this  Agreement,  any reference to a "Parent  Material  Adverse  Effect"
means any change,  event or effect that is  materially  adverse to the financial
condition,  properties, assets, liabilities,  business, operations or results of
operations of Parent and its subsidiaries,  taken as a whole; provided, however,
that  any  adverse  change,  effect,  event,  occurrence,   state  of  facts  or
development  attributable  to conditions  affecting the industries as a whole in
which Parent and its subsidiaries  participates,  the U.S. economy as a whole or
the foreign  economies  as a whole in any  locations  where Parent or any of its
subsidiaries has material operations or sales shall not be taken into account in
determining whether there has been or will be, a Parent Material Adverse Effect.

     Except as  disclosed  in any  Parent  SEC  Document  or as  disclosed  in a
document of even date  herewith and  delivered by Parent to Company prior to the
execution and delivery of this  Agreement  and referring to the  representations
and warranties in this Agreement (the "Parent  Disclosure  Schedule"),  provided
that any disclosure  shall qualify the section number  referred to in the Parent
Disclosure Schedule as well as all other sections in this Article III when it is
reasonably  apparent from a reading of such disclosure that it also qualifies or
applies to such other  sections,  provided  further  that Parent  shall make all
reasonable  efforts to  specifically  cross  reference in the Parent  Disclosure
Schedule all sections where a particular disclosure qualifies or applies, Parent
represents and warrants to the Company as follows:

     3.1 Organization,  Standing and Power. Parent and each of its subsidiaries,
         ---------------------------------
including Merger Sub, are corporations  duly organized,  validly existing and in
good standing under the laws of their respective  jurisdictions of organization.
Each of Parent and its  subsidiaries,  including  Merger Sub, have the corporate
power to own  their  respective  properties  and to  carry  on their  respective

                                       25



businesses  as now being  conducted and as proposed to be conducted and are each
duly qualified to do business and are in good standing in each  jurisdiction  in
which the failure to be so qualified  and in good  standing  would have a Parent
Material Adverse Effect.  Neither Parent nor any of its subsidiaries,  including
Merger  Sub,  is in  violation  of  any  of the  provisions  of  its  respective
Certificate of Incorporation or Bylaws or equivalent  organizational  documents.
Parent is the owner of all  outstanding  shares of capital  stock of each of its
subsidiaries and all such shares are duly authorized, validly issued, fully paid
and  non-assessable.  Parent does not directly or  indirectly  own any equity or
similar interest in, or any interest  convertible or exchangeable or exercisable
for, any equity or similar  interest  in, any  corporation,  partnership,  joint
venture or other  business  association or entity,  excluding  securities in any
publicly  traded company held for investment by Parent or any of it subsidiaries
in accordance  with and pursuant to the Parent's  formal  investment  policy and
comprising less than 5% of the outstanding stock of such company.

     3.2 Capital Structure.
         -----------------

     (a) The authorized capital stock of Parent consists of 50,000,000 shares of
Parent Common Stock of which there were 9,115,779  shares issued and outstanding
as of the Execution Date. There are no other outstanding shares of capital stock
or voting  securities  and no  outstanding  commitments  to issue any  shares of
capital stock or voting  securities,  other than pursuant to the exercise of (i)
options  outstanding  as of such date  under  the 1996  Employee,  Director  and
Consultant  Stock Option Plan (the "Parent Stock Option Plan") and (ii) warrants
(the  "Warrants")  for 1,274,000  shares of Parent Common Stock.  The authorized
capital stock of Merger Sub consists of 2,500,000  shares of Common  Stock,  par
value $.01 per share, of which 100 shares are issued and outstanding and held by
Parent.  The shares of Parent Common Stock to be issued in the Merger will, upon
issuance, be duly authorized,  validly issued, fully paid and non-assessable and
registered with the SEC pursuant to the Securities Act.

     (b) All  outstanding  shares of Parent  Common  Stock are duly  authorized,
validly  issued,  fully  paid and  non-assessable  and are free of any  liens or
encumbrances,  other than any liens or  encumbrances  created by or imposed upon
the holders thereof, and are not subject to preemptive rights or rights of first
refusal created by Delaware Law, the Certificate of  Incorporation  or Bylaws of
Parent or any  agreement to which Parent is a party or by which it is bound.  As
of the Execution Date, Parent has reserved (i) 4,339,708 shares of Parent Common
Stock for  issuance to  directors,  employees  and  consultants  pursuant to the
Parent Stock Option Plan, and (ii)  1,274,000  shares of Parent Common Stock for
issuance  pursuant to the Warrants.  On the Execution  Date,  except for (i) the
rights created pursuant to this Agreement,  the Parent Stock Option Plan and the
Warrants and (ii)  Parent's  right to repurchase  any unvested  shares under the
Parent Stock Option Plan, there are no other options,  warrants,  calls, rights,
commitments  or  agreements  of any  character  to which Parent is a party or by
which it is bound  obligating  Parent to issue,  deliver,  sell,  repurchase  or
redeem, or cause to be issued,  delivered,  sold,  repurchased or redeemed,  any
shares of Parent Capital Stock or obligating Parent to grant, extend, accelerate
the vesting of,  change the price of, or otherwise  amend or enter into any such
option, warrant, call, right, commitment or agreement.


                                       26



     3.3 Authority.
         ---------

     (a)  Parent  and Merger  Sub each have all  requisite  corporate  power and
authority  to enter  into this  Agreement  and to  consummate  the  transactions
contemplated  hereby.  The  execution  and  delivery of this  Agreement  and the
consummation of the transactions  contemplated  hereby have been duly authorized
by all necessary  corporate action on the part of each of Parent and Merger Sub,
as applicable, other than approval by the shareholders of Parent.

     (b) This  Agreement  has been duly executed and delivered by each of Parent
and Merger Sub, as applicable, and constitutes the valid and binding obligations
of each of Parent and  Merger Sub  enforceable  against  each by the  Company in
accordance with its terms.  The execution and delivery of this Agreement do not,
and the  consummation of the transactions  contemplated  hereby and thereby will
not,  conflict  with,  or result in any  violation of, or default under (with or
without  notice  or  lapse  of  time,  or  both),  or give  rise  to a right  of
termination, cancellation or acceleration of any obligation or loss of a benefit
under (i) any provision of the Certificate of Incorporation or Bylaws of Parent,
Merger  Sub or any of  their  respective  subsidiaries,  or  (ii)  any  material
mortgage,  indenture, lease, contract or other agreement or instrument,  permit,
concession,   franchise,   license,   judgment,  order,  decree,  statute,  law,
ordinance,  rule  or  regulation  applicable  to  Parent,  Merger  Sub or  their
respective  subsidiaries,  properties  or assets,  except  where such  conflict,
violation,  default,  termination,  cancellation or acceleration with respect to
the foregoing  provisions in subsection (ii) would not have had and would not be
reasonably expected to have a Parent Material Adverse Effect.

     (c) Except as otherwise would not have a Parent Material Adverse Effect, no
consent,  approval,  order or authorization of, or registration,  declaration or
filing with,  any  Governmental  Entity,  is required  with respect to Parent or
Merger Sub in connection  with the  execution and delivery of this  Agreement by
Parent  and  Merger  Sub or the  consummation  by Parent  and  Merger Sub of the
transactions  contemplated hereby and thereby,  except for (i) the filing of the
Certificate of Merger,  together with the required  officers'  certificates,  as
provided  in  Section  1.2,  (ii)  the  filing  with the SEC and the AMEX of the
Registration  Statement,  (iii) any filings as may be required under  applicable
federal,  state and local securities laws and the securities laws of any foreign
country,  (iv) the filing  with the AMEX for the listing of the shares of Parent
Common Stock issuable upon  conversion of the Company Common Stock in the Merger
and upon  exercise of the Company  Options  under the Company Stock Option Plans
assumed by Parent in the  Merger,  to the extent  required,  (v) the filing of a
registration  statement  on Form  S-8 with the  SEC,  or other  applicable  form
covering the shares of Parent  Common  Stock  issuable  pursuant to  outstanding
Company  Options  under the Company  Stock Option Plans assumed by Parent in the
Merger;  and (vi) such other consents,  authorizations,  filings,  approvals and
registrations  which,  if not obtained or made,  would not  prevent,  materially
alter or delay any of the transactions contemplated by this Agreement.



                                       27





     3.4 SEC Documents; Financial Statements.
         -----------------------------------

     (a) Parent has made  available to the Company a true and  complete  copy of
each statement,  report, registration statement (with the prospectus in the form
filed  pursuant  to  Rule  424(b)  of  the  Securities  Act),  definitive  proxy
statement,  and other filing filed with the SEC by Parent since  January 1, 2000
(collectively,  the "Parent SEC Documents").  Parent has not filed any documents
with the SEC that are not  available  through  EDGAR since  January 1, 2000.  In
addition,  Parent has made  available  to the Company all exhibits to the Parent
SEC Documents  filed prior to the date hereof,  and will promptly make available
to the Company all exhibits to any additional  Parent SEC Documents  filed prior
to the Effective  Time. To Parent's  knowledge,  as of their  respective  filing
dates,  the Parent SEC  Documents  complied in all  material  respects  with the
requirements  of the  Exchange  Act and the  Securities  Act  and,  to  Parent's
knowledge,  none of the Parent SEC Documents contained any untrue statement of a
material fact or omitted to state a material fact required to be stated  therein
or necessary to make the statements made therein,  in light of the circumstances
in which  they  were  made,  not  misleading,  except to the  extent  corrected,
supplemented or superseded by a subsequently filed Parent SEC Document.

     (b) The  financial  statements  of  Parent,  including  the notes  thereto,
included in the Parent SEC Documents (the "Parent Financial Statements") and the
unaudited  balance  sheet of  Parent,  dated as of June 30,  2002  (the  "Parent
Balance Sheet Date"),  were complete and correct in all material  respects as of
their  respective  dates,  complied  as to form in all  material  respects  with
applicable accounting  requirements and with the published rules and regulations
of the SEC with  respect  thereto as of their  respective  dates,  and have been
prepared in accordance  with GAAP applied on a basis  consistent  throughout the
periods  indicated and consistent with each other (except as may be indicated in
the notes thereto or, in the case of unaudited statements, included in Quarterly
Reports on Form  10-QSBs,  as permitted  by Form 10-QSB of the SEC).  The Parent
Financial  Statements  fairly present in all material  respects the consolidated
financial  condition and operating results of Parent as of the dates and for the
periods  indicated  therein (subject,  in the case of unaudited  statements,  to
normal,   recurring   year-end   adjustments).   There  have  been  no  material
disagreements  between  Parent and its auditors  with  respect to the  treatment
and/or characterization of items contained in the Parent Financial Statements.

     (c) Parent has fully complied with all certification requirements, and will
comply with all  certification  requirements  prior to the Effective Time, under
the Sarbanes-Oxley Act of 2002.

     3.5 Absence of Certain  Changes.  Except as expressly  contemplated by this
         ---------------------------
Agreement, since the Parent Balance Sheet Date there has not occurred and on the
Closing  Date there will not have  occurred  (except as permitted by Section 4.3
hereof): (i) any change, event or condition (whether or not covered by insurance
or similar indemnification  agreement) that has resulted in, or would reasonably
be  expected  to  result  in,  a  Parent  Material  Adverse  Effect,   (ii)  any
acquisition,  sale  or  transfer  of  any  material  asset  of  Parent  and  its
subsidiaries, (iii) any change in accounting methods or practices (including any
change  in  depreciation  or  amortization  policies  or rates) by Parent or any
revaluation by Parent of any of its and its subsidiaries'  material assets, (iv)


                                       28



any declaration,  setting aside, or payment of a dividend or other  distribution
with  respect to the  shares  Parent  Common  Stock,  or any direct or  indirect
redemption,  purchase  or other  acquisition  by Parent of any of the  shares of
Parent  Common  Stock,  (v) any  action to amend or change  the  Certificate  of
Incorporation  or  Bylaws of Parent  (nor will  there be prior to the  Effective
Time), or (vi) any negotiation or agreement by Parent or any of its subsidiaries
to do any of the things  described  in the  preceding  clauses  (i)  through (v)
(other than negotiations with the Company and its representatives  regarding the
transactions contemplated by this Agreement).

     3.6  Absence of  Undisclosed  Liabilities.  Except as set forth on Schedule
          ------------------------------------
3.6, Parent has no material obligations or liabilities of any nature (matured or
unmatured,  fixed or  contingent)  other than: (i) those set forth or adequately
reflected or reserved against on the balance sheet or in the notes to the Parent
Financial Statements for the period ended on the Parent Balance Sheet Date, (ii)
those incurred in the ordinary course of business since the Parent Balance Sheet
Date,  and  (iii)  those  incurred  in  connection  with the  execution  of this
Agreement.

     3.7  Litigation.  There is no  Proceeding  pending or, to the  knowledge of
          ----------
Parent,  threatened  against  Parent,  any of its  subsidiaries  or any of their
respective properties or any of their respective officers or directors (in their
capacities as such). There is no judgment, decree or order against Parent or any
of its  subsidiaries,  or, to the knowledge of Parent,  any of their  respective
directors or officers (in their capacities as such), that could prevent, enjoin,
or  materially  alter  or delay  any of the  transactions  contemplated  by this
Agreement,  or that  could  reasonably  be  expected  to have a Parent  Material
Adverse  Effect.  Notwithstanding  the foregoing,  no judgment,  decree or order
arising from or relating to any  proceeding  disclosed in the Parent  Disclosure
Schedule or the Parent SEC Documents  shall be deemed to constitute or give rise
to any breach of this Section 3.7.

     3.8 Governmental  Authorization.  Parent has obtained each federal,  state,
         ---------------------------
county, local or foreign governmental consent,  license, permit, grant, or other
authorization of a Governmental  Entity:  (i) pursuant to which Parent currently
operates or holds any interest in any of its properties or (ii) that is required
for the operation of Parent's  business or the holding of any such interest ((i)
and (ii) herein collectively called the "Parent Authorizations"), and all of the
Parent  Authorizations are in full force and effect, except where the failure to
obtain or have any Parent  Authorization does not have a Parent Material Adverse
Effect.

     3.9  Environmental  Laws.  Except as  disclosed  on  Schedule  3.9,  Parent
          -------------------
represents and warrants as follows:

     (a) The  operations  of Parent have at all times been and are in compliance
with all Environmental  Laws,  except where any  noncompliance  would not have a
Parent Material Adverse Effect.

     (b) Parent has obtained and is in full  compliance  with all  Environmental
Approvals,  each such  Environmental  Approval is in full force and effect,  and
each such Environmental  Approval will remain in full force and effect after the

                                       29



execution,  delivery and  performance of this  Agreement,  provided any transfer
documents  required by  Environmental  Law for such  Environmental  Approval and
identified on Schedule 3.9(b) are completed as required by Environmental Law.


     (c) Neither  Parent nor any of its  properties  or facilities is subject to
any  Order  (as  defined  in  Section   5.6(b))  or  proposed  Order  under  any
Environmental  Law.  Parent  has not  received  any  notice  from any  person or
Governmental  Entity  regarding  or alleging,  and no condition or  circumstance
exists that is reasonably  likely to result in (with or without  notice or lapse
of time or both) a violation  or failure to comply with any term or  requirement
of any Environmental Law or Environmental Approval.

     (d) Parent has provided or made available to the Company true, complete and
correct  copies  and  results of all  studies,  reports,  assessments,  surveys,
correspondence,  investigations,  audits,  analysis,  tests and other  documents
(whether  in  hard  copy  or  electronic  form)  in  Parent's  or its  counsel's
possession  or control  pertaining  to the  presence or alleged  presence of any
Hazardous  Material at, on or affecting any of its properties or facilities,  or
regarding  Parent's   compliance  with  any  applicable   Environmental  Law  or
Environmental Approval.


     (e) To  Parent's  knowledge,  none of the  following  exists  at any of its
properties or facilities: any asbestos-containing  material in any form which is
friable; urea formaldehyde foam insulation; polychlorinated biphenyls; active or
out-of-service  or  underground  storage  tanks or sites from which such storage
tanks have been removed; or landfills, surface impoundments, waste piles or land
disposal areas.


     (f) To Parent's  knowledge,  Parent is not a potentially  responsible party
under  the  federal  Comprehensive  Environmental  Response,   Compensation  and
Liability Act (CERCLA), or state analog statute, arising out of events occurring
prior to the Closing Date.

     3.10 Taxes.  Parent and each of its  subsidiaries  has timely filed all Tax
          -----
Returns that it was required to file, and such Tax Returns are true, correct and
complete  in all  material  respects.  All Taxes shown to be payable on such Tax
Returns or on subsequent assessments with respect thereto have been paid in full
on a timely  basis,  and no other Taxes are payable by Parent or any  subsidiary
with respect to any period  ending prior to the Execution  Date,  whether or not
shown due or reportable on such Tax Returns, other than Taxes for which adequate
accruals  have been  provided  in the  Parent  Financial  Statements  or amounts
payable with respect to periods or portions of periods after the Parent  Balance
Sheet Date.  Parent and each of its  subsidiaries has withheld and paid over all
Taxes  required  to have been  withheld  and paid over,  and  complied  with all
information reporting and backup withholding requirements, including maintenance
of required records with respect thereto.  Neither Parent nor any subsidiary has
any material  liability for unpaid Taxes accruing after the Parent Balance Sheet
Date, except for Taxes incurred in the ordinary course of business. There are no
liens for Taxes on the  properties of Parent or any of its  subsidiaries,  other
than liens for Taxes not yet due and payable.




                                       30


     3.11 Compliance With Laws. Each of Parent and its subsidiaries has complied
          --------------------
with, is not in violation of, and has not received any notices of violation with
respect to any federal,  state, local or foreign statute, law or regulation with
respect to the conduct of its  business,  or the  ownership  or operation of its
business, except for such violations or failures to comply that would not have a
Parent Material Adverse Effect.

     3.12  Brokers'  and Finders'  Fees.  Parent has not  incurred,  nor will it
           ----------------------------
incur,  directly or indirectly,  any liability for brokerage or finders' fees or
agents'  commissions  or  investment  bankers'  fees or any  similar  charges in
connection with this Agreement, the Merger or any other transaction contemplated
hereby.

     3.13 Vote Required.  The  affirmative  vote of the holders of a majority of
          -------------
the shares of Parent Common Stock outstanding is the only vote of the holders of
any of the  securities  or capital  stock of Parent  necessary  to approve  this
Agreement and the transactions contemplated hereby.

     3.14 Board and Shareholder Approval.  The Boards of Directors of Parent and
          ------------------------------
Merger Sub have (i) approved this Agreement and the Merger,  and (ii) determined
that the Merger is in the best interests of their respective shareholders and is
on terms that are fair to such  shareholders,  and (iii)  resolved to  recommend
that their respective shareholders approve this Agreement and the Merger.

     3.15  Registration  Statement;   Proxy  Statement/Proxy.   The  information
           -------------------------------------------------
relating  to Parent  which is  provided  by Parent  (including  any  information
previously  provided by Parent in the Parent SEC Documents) for inclusion in the
Registration  Statement  shall not, at the time the  Registration  Statement  is
declared  effective by the SEC and at all times subsequent  thereto (through and
including the Effective  Time),  contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary in
order to make the statements  therein, in light of the circumstances under which
they were made,  not  misleading.  The  information  relating to Parent which is
provided by Parent (including any information  previously  provided by Parent in
the Parent SEC Documents) for inclusion in the Proxy Statement shall not, on the
date the Proxy  Statement  is  mailed to the  shareholders  of the  Company  and
Parent, at the time of the Company Shareholders Meeting, the Parent Shareholders
Meeting and at the Effective  Time,  contain any untrue  statement of a material
fact or omit to state  any  material  fact  required  to be  stated  therein  or
necessary in order to make the statements therein, in light of the circumstances
under which they were made,  not  misleading;  or omit to state a material  fact
necessary to correct any statement in an earlier  communication  with respect to
the  solicitation  of proxies  for the  Company  Shareholders  Meeting or Parent
Shareholders  Meeting which has become false or misleading.  Notwithstanding the
foregoing, Parent makes no representation,  warranty or covenant with respect to
any  information  supplied by the  Company or  relating to the Company  which is
contained in the Registration Statement or the Proxy Statement.

     3.16 Tax  Matters.  To  Parent's  knowledge  neither  Parent nor any of its
          ------------
affiliates  has  taken or  agreed  to take any  action,  nor  does  Parent  have


                                       31



knowledge  of any fact or  circumstance,  that would  prevent  the  Merger  from
qualifying as a reorganization within the meaning of Section 368(a) of the Code.

     3.17 Investigation by Parent; Company's Liability. Parent has conducted its
          --------------------------------------------
own independent investigation,  review and analysis of the business, operations,
assets,  liabilities,  results of  operations,  financial  condition,  software,
technology  and  prospects  of the  Company,  which  investigation,  review  and
analysis was done by Parent and its affiliates  and, to the extent Parent deemed
appropriate,  by Parent's  representatives.  Parent acknowledges that it and its
representatives have been provided adequate access to the personnel, properties,
premises and records of the Company its subsidiaries as Parent has requested for
such purpose.  In entering into this Agreement,  Parent acknowledges that it has
relied solely upon the aforementioned investigation, review and analysis and not
on any  factual  representations  or  opinions  of the  Company's  or any of the
Company's representatives (except the specific representations and warranties of
the Company set forth in this  Agreement and the Company  Disclosure  Schedule).
Parent has formed an independent judgment concerning the Company.

     3.18  Material  Third  Party  Consents.  Schedule  3.18 lists all  Parent's
           --------------------------------
material contracts or agreements required to be disclosed pursuant to Item 10 of
Regulation  S-K under the SEC rules and  regulations  that require a novation or
consent to the Merger prior to the  Effective  Time so that such  contracts  may
remain in full  force  and  effect  after the  Closing  (the  "Parent  Contracts
Requiring Novation or Consent") which, if no novation occurs or if no consent to
the Merger is obtained, would have a Parent Material Adverse Effect.





















                                       32




                                   ARTICLE IV

                       CONDUCT PRIOR TO THE EFFECTIVE TIME

     4.1 Conduct of Business of the Company.
         ----------------------------------

     (a) During the period  from the  Execution  Date and  continuing  until the
earlier of the  termination of this Agreement or the Effective Time, the Company
agrees (except to the extent expressly  contemplated by this Agreement,  Section
4.1(b) hereof or as consented to in writing by Parent), to carry on its business
in the usual,  regular and ordinary course in  substantially  the same manner as
heretofore  conducted.  Subject to Section  4.1(b) hereof,  the Company  further
agrees to pay all debts and Taxes when due,  subject to (i) good faith  disputes
over such debts or Taxes and (ii) the filing of material Tax Returns,  to pay or
perform other obligations when due, and to use all reasonable efforts consistent
with past  practice  and  policies  to  preserve  intact  its  present  business
organizations,  to keep  available the services of its present  officers and key
employees  and to use its  commercially  reasonable  efforts  and its  available
resources to preserve its relationships with customers, suppliers, distributors,
licensors,  licensees  and others having  business  dealings with it, to the end
that its goodwill and ongoing  businesses  shall be  unimpaired at the Effective
Time,  other than what would not have a Company  Material  Adverse  Effect.  The
Company  agrees to promptly  notify Parent in writing of any event or occurrence
not in the  ordinary  course  of its  business,  and of any  event  which  could
reasonably be expected to have a Company Material Adverse Effect.

     (b) Without  limiting the generality of Section  4.1(a),  during the period
from the Execution Date and continuing  until the earlier of the  termination of
this  Agreement  or the  Effective  Time,  except  as set  forth in the  Company
Disclosure Schedule or as expressly contemplated by this Agreement,  the Company
shall not do, cause or permit any of the  following,  without the prior  written
consent of Parent (which consent shall not be unreasonably withheld or delayed):

     (i) Cause or permit any  amendments  to its  Articles of  Incorporation  or
Bylaws;

     (ii)  Declare  or pay any  dividends  on or make  any  other  distributions
(whether in cash,  stock or property) in respect of any of its capital stock; or
split,  combine or reclassify any of its capital stock or issue or authorize the
issuance of any other  securities  in respect of, in lieu of or in  substitution
for shares of its capital stock, or repurchase or otherwise acquire, directly or
indirectly, any shares of its capital stock;

     (iii)  Accelerate,  amend or change the period of exercisability or vesting
of options,  securities or other rights granted under the Company Options or the
Company  Stock  Option  Plans or  authorize  cash  payments in exchange  for any
options or other rights granted under any of the above,  except in each case, to
the extent  required by the existing terms of any such Company Option or Company
Stock Option Plan,  which has not been amended or otherwise  modified to provide


                                       33



such change to acceleration,  period of  exercisability or vesting within thirty
(30) days prior to the Execution Date;

     (iv) Enter into any material  contract or  commitment  (including,  without
limitation, any contracts with employees, officers, directors or shareholders or
any material  operating lease),  or violate,  amend or otherwise modify or waive
any  of  the  terms  of  any  of  the  Material  Contracts  (including,  without
limitation, any contracts with employees,  officers,  directors or shareholders)
other than in the ordinary  course of business;  provided,  further,  that other
than in the ordinary  course of business,  the Company  shall not enter into any
contract,  commitment  or agreement  (x) which grants any third party  exclusive
rights,  (y) which  provides any third party with  equity,  as  compensation  or
otherwise,  or (z) with any third party which could reasonably be deemed to be a
competitor of Parent;

     (v) Issue,  deliver or sell or authorize or propose the issuance,  delivery
or sale of, or purchase or propose  the  purchase  of, any shares of its capital
stock or securities  convertible  into, or  subscriptions,  rights,  warrants or
options  to  acquire,  or  other  agreements  or  commitments  of any  character
obligating it to issue any such shares or other  convertible  securities,  other
than the issuance of shares of Company Common Stock pursuant to (x) the exercise
of Company  Options  issued and  outstanding  on the date hereof,  and (y) other
rights  therefor  outstanding  as of the date of this Agreement and disclosed in
the Company Disclosure Schedule;

     (vi) Sell, lease, license (either exclusively or non-exclusively), encumber
or otherwise transfer or dispose of any patents, patent applications, trademarks
(whether  registered or not),  copyrights  (whether  registered  or not),  trade
secret information or any other  intellectual  property material to the business
of the Company, or any interests therein;

     (vii) Sell,  lease,  license or otherwise dispose of or encumber any of its
properties or assets which are material,  individually  or in the aggregate,  to
its  business,  taken as a whole  except for sales of products  in the  ordinary
course of business;

     (viii) Incur any  indebtedness  for borrowed  money under  existing  credit
lines or  otherwise,  except as  reasonably  necessary  for the operation of its
business  in a  manner,  and in  amounts,  consistent  with past  practices,  or
guarantee  any  such  indebtedness  or issue  or sell  any  debt  securities  or
guarantee any debt securities of others;

     (ix) Pay any  amount in excess of $25,000 in any one case or $50,000 in the
aggregate  arising for any reason other than in accordance with the terms of any
claim,  liability or  obligation  of the Company;  provided,  however,  that the
Company  may pay any such  amounts  to the  extent  that they are  reflected  or
reserved against in the Company Financial Statements;

     (x)  Make  any  capital   expenditures,   capital   additions   or  capital
improvements  except in the ordinary course of business and consistent with past
practice, and not withstanding the above, make any such expenditures,  additions
or  improvements  in  excess  of  $50,000  in any one  case or  $100,000  in the
aggregate;   provided,   however,   that  the   Company  may  make  any  capital

                                       34


expenditures,  capital additions or capital  improvements related to the capital
projects listed on Schedule 4.1(b)(x);

     (xi)  Materially  reduce the amount of any insurance  coverage  provided by
existing insurance policies;

     (xii)  Terminate or waive any right of any material or  substantial  value,
except in the ordinary course of business;

     (xiii)  Adopt or amend any  employee  benefit or stock  purchase  or option
plan,  except as required  under ERISA or except as  necessary  to maintain  the
qualified  status of such plan under the Code, or hire any new director level or
executive  officer level employee,  or increase the annual level of compensation
of any  employee,  or grant any unusual or  extraordinary  bonuses,  benefits or
other  forms of  direct  or  indirect  compensation  to any  employee,  officer,
director or consultant, except in the ordinary course of business and in amounts
consistent with past practices;

     (xiv) Grant any severance or termination pay (x) to any director or officer
or  (y) to  any  other  employee,  except  payments  made  pursuant  to  written
agreements outstanding on the Execution Date;

     (xv)  Commence  any  material  lawsuit  other  than  (x)  for  the  routine
collection of bills,  (y) in such cases where it in good faith  determines  that
failure to commence  suit would result in the material  impairment of a valuable
aspect of its  business,  provided  that it consults  with  Parent  prior to the
filing of such a suit,  or (z) for a breach of this  Agreement  or any  Exhibits
hereto;

     (xvi) Acquire or agree to acquire by merging or  consolidating  with, or by
purchasing a substantial  portion of the assets of, or by any other manner,  any
business  or  any  corporation,   partnership,  association  or  other  business
organization or division  thereof,  or otherwise acquire or agree to acquire any
assets which are material,  individually  or in the aggregate,  to its business,
taken as a whole;

     (xvii)  Other than in the ordinary  course of  business,  or as required by
GAAP, make or change any material election in respect of Taxes,  adopt or change
any accounting  method in respect of Taxes,  file any material Tax Return or any
amendment to a material Tax Return, enter into any closing agreement, settle any
claim or assessment  in respect of Taxes,  or consent to any extension or waiver
of the  limitation  period  applicable  to any claim or assessment in respect of
Taxes;

     (xviii) Revalue any of its assets,  including  without  limitation  writing
down the value of  inventory or writing off notes or accounts  receivable  other
than in the ordinary course of business; or

     (xix) Adopt a plan of complete or partial liquidation or dissolution; or


                                       35



     (xx) Take or agree in  writing or  otherwise  to take,  any of the  actions
described in Sections  4.1(b)(i)  through (xix) above, or any action which would
make any of its representations or warranties contained in this Agreement untrue
or incorrect in any material  respect or prevent it from  performing or cause it
not to perform its covenants hereunder.

     4.2 Conduct of Business of Parent.
         -----------------------------

     (a) During the period  from the  Execution  Date and  continuing  until the
earlier of the  termination  of this  Agreement or the  Effective  Time,  Parent
agrees (except to the extent expressly  contemplated by this Agreement,  Section
4.2(b)  hereof or as  consented to in writing by the  Company),  to carry on its
business in the usual,  regular and ordinary  course in  substantially  the same
manner as heretofore conducted.

     (b) Without  limiting the generality of Section  4.2(a),  during the period
from the Execution Date and continuing  until the earlier of the  termination of
this  Agreement  or the  Effective  Time,  except  as set  forth  in the  Parent
Disclosure Schedule or as expressly contemplated by this Agreement, Parent shall
not do, cause or permit any of the following,  without the prior written consent
of the Company (which consent shall not be unreasonably withheld or delayed):

          (i) Cause or permit any amendments to its Certificate of Incorporation
or Bylaws;

          (ii) Issue,  deliver or sell or  authorize  or propose  the  issuance,
delivery  or  sale  of, or  purchase or  propose the  purchase of, any shares of
its  capital  stock  or  securities  convertible into, or subscriptions, rights,
warrants  or  options  to  acquire,  or  other  agreements or commitments of any
character  obligating  it  to   issue  any  such  shares  or  other  convertible
securities,  other  than  (x)  the  issuance  of   employee  stock  options,  or
shares  of  Parent  Common  Stock upon exercise  therefor,  pursuant to plans in
effect  on  the  Execution  Date;  (y) the  other  rights  for  shares of Parent
Common  Stock  outstanding  as of  the date of this Agreement and  disclosed  in
the Parent Disclosure Schedule;

          (iii) Fail to maintain the trading of the Parent Common Stock on AMEX;

          (iv) Adopt a plan of complete or partial  liquidation or  dissolution;
or

          (v) Take or agree in writing or otherwise to take,  any of the actions
described  in  Sections  4.2(b)(i)  through  (iv)  above,  or  any  action which
would  make  any  of  its  representations  or  warranties  contained   in  this
Agreement  untrue  or  incorrect  in  any  material  respect  or prevent it from
performing or cause it not to perform its covenants hereunder.


     4.3 No Solicitation.
         ---------------

     (a) The Company and the officers,  directors,  employees or other agents of
the Company will not,  directly or  indirectly,  (i) take any action to solicit,
initiate or intentionally  encourage any Takeover Proposal (as defined below) or
(ii) subject to the terms of Section  4.3(b) below,  take any action to solicit,

                                       36



intentionally  facilitate,  intentionally encourage or engage in negotiations or
discussions with, or disclose any nonpublic  information relating to the Company
to, or afford access to the properties,  books or records of the Company to, any
Person that has advised the Company in writing that it intends to make,  or that
has made, a Takeover  Proposal;  provided,  nothing  herein  shall  prohibit the
Company's  Board  of  Directors  from  complying  with  Rules  14d-9  and  14e-2
promulgated under the Exchange Act with regard to a tender or exchange offer.

     (b)  Notwithstanding  Section  4.3(a)  above,  if  an  unsolicited  written
Takeover  Proposal,  or an unsolicited  written  expression of interest that can
reasonably be expected to lead to a Takeover Proposal,  is received by the Board
of Directors of the Company,  then: (i) if none of the Company and its officers,
directors,  employees or other agents and  representatives  have violated in any
material  respect any of the  restrictions  in Section  4.3(a),  and (ii) to the
extent the Board of  Directors  of the  Company  believes  in good faith  (after
consultation  with its financial  advisors)  that such Takeover  Proposal  would
reasonably be expected to result in a transaction  that is more favorable to the
Company's shareholders than the transaction  contemplated by this Agreement (any
such more favorable  Takeover  Proposal being referred to in this Agreement as a
"Superior Proposal"),  and (iii) the Board of Directors of Company determines in
good faith (after  consultation with outside legal counsel) that failure to take
action with respect to such Superior  Proposal  would be  inconsistent  with the
fiduciary  duties of the Board of  Directors  of the  Company  to the  Company's
shareholders  under  applicable  law, the Company and its  officers,  directors,
employees,  investment bankers, financial advisors,  attorneys,  accountants and
other  representatives  retained  by it may  furnish in  connection  with such a
Superior  Proposal  information and take such other actions with respect to such
Superior Proposal as are consistent with the fiduciary  obligations of Company's
Board of  Directors,  and such actions with  respect to such  Superior  Proposal
shall not be considered a breach of Section  4.3(a),  provided that in each such
event  Company:  (A)  notifies  Parent in writing of such  determination  by the
Company's  Board of  Directors,  and (B)  provides  Parent with a summary of the
Superior Proposal received from such third party so long as such disclosure does
not cause the breach of any non-disclosure or confidentiality  agreements of the
Company  outstanding as of the Execution Date.  Notwithstanding  the immediately
preceding  sentence,  neither the Company nor its  representatives  may take any
action with respect to a Superior  Proposal  unless and until:  (x) the Board of
Directors  of Company has  determined,  after  consultation  with the  Company's
investment  bankers,  that such  third  party is  actually  capable  of making a
Superior Proposal upon  satisfactory  completion of such third party's review of
the information  supplied by the Company,  and (y) such third party executes and
delivers to the Company a non-disclosure or confidentiality agreement containing
provisions   regarding   non-disclosure   at   least  as   restrictive   as  the
Confidentiality Agreement (as defined in Section 5.4).

     Additionally,  the  Company  shall  not,  and shall not  permit  any of its
officers,  directors,  employees  or  other  representatives  to,  agree  to  or
intentionally  endorse any Takeover Proposal  (including any Superior Proposal),
unless Parent or the Company  terminates  this Agreement and the Company pays to
Parent all amounts payable to Parent pursuant to Sections 7.3(b) and (c) hereof,
as applicable.

                                       37



     (c) The Company will promptly notify Parent after receipt,  but in no event
later than 24 hours from such  receipt,  of any Takeover  Proposal or any notice
that any Person is  considering  making a Takeover  Proposal  or any request for
non-public  information relating to the Company or for access to the properties,
books or records of the Company by any Person that has advised the Company  that
it may be considering making, or that has made, a Takeover Proposal.

     (d) For purposes of this Agreement,  "Takeover Proposal" means any offer or
proposal  for, or any  indication  of interest in (whether  written or oral),  a
merger or other business combination involving the Company or the acquisition of
more than 25% of the  Company  Capital  Stock,  a material  portion of the total
assets  or any  material  asset of the  Company,  other  than  the  transactions
contemplated by or disclosed in this Agreement.

                                    ARTICLE V

                              ADDITIONAL AGREEMENTS

     5.1 Proxy Statement/Prospectus;  Registration Statement. Promptly after the
         ---------------------------------------------------
execution  of this  Agreement,  the Company and Parent  shall  prepare the Proxy
Statement  and  Parent  shall  prepare  and file  with the SEC the  Registration
Statement,  which  Registration  Statement  shall  contain the Proxy  Statement.
Parent shall ensure that the  Registration  Statement and Proxy Statement comply
in form  with  applicable  SEC  requirements  and  shall  use  all  commercially
reasonable  efforts to cause the  Registration  Statement to become effective as
promptly as  practicable  after  filing.  If, at any time prior to the Effective
Time, any event or information  should be discovered by the Company which should
be set forth in a supplement to the Proxy Statement,  the Company shall promptly
inform Parent in writing.  The Proxy Statement shall include the  recommendation
of the  Board  of  Directors  of the  Company  and  Parent  that  the  Company's
shareholders and Parent's  shareholders  vote in favor of the Merger and approve
this Agreement;  provided that such recommendation may be excluded or withdrawn,
to the extent the Company complies with Sections 4.3(b) and 7.3, in the event of
a  Superior  Proposal.  Parent  shall  take any action  reasonably  (other  than
qualifying to do business in any  jurisdiction in which is now not so qualified)
required to be taken under any applicable  state  securities  laws in connection
with the  issuance  of Parent  Common  Stock in the Merger and upon  exercise of
Company Stock Options.

     5.2 Meeting of  Shareholders.  The Company  shall  promptly  after the date
         ------------------------
hereof take all action  necessary  in  accordance  with  California  Law and its
Articles of  Incorporation  and Bylaws to call, give notice of, convene and hold
the Company Shareholders Meeting, as promptly as is reasonably practicable,  and
in any event  within  forty-five  (45) days after the SEC has  cleared the Proxy
Statement and declared the effectiveness of the Registration  Statement.  Parent
shall  promptly  after the date hereof take all action  necessary in  accordance
with  Massachusetts  Business  Corporation  Law  ("Massachusetts  Law")  and its
Certificate  of  Incorporation  and Bylaws to call,  give notice of, convene and
hold the Parents Shareholders Meeting, as promptly as is reasonably practicable,
and in any event within forty-five (45) days after the SEC has cleared the Proxy

                                       38



Statement and declared the  effectiveness  of the  Registration  Statement.  The
Company  and Parent  shall  consult  with each other  regarding  the date of the
Company  Shareholders  Meeting  and Parent  Shareholders  Meeting  and shall not
postpone  or  adjourn  (other  than for the  absence  of a quorum)  the  Company
Shareholders  Meeting or Parent Shareholders  Meeting without the consent of the
other party,  unless this Agreement is first terminated  pursuant to Article VII
hereof.  Subject to  Sections  4.3 and 5.1,  the  Company  and Parent  shall use
commercially  reasonable  efforts to solicit from their respective  shareholders
proxies in favor of the Merger and shall take all other commercially  reasonable
actions  that are  necessary  or advisable to secure the vote or consent of such
shareholders  to effect the Merger,  as  required by the rules of Nasdaq,  AMEX,
California Law,  Massachusetts Law, Delaware Law or other applicable laws, rules
or regulations.

     5.3 Access to Information; Disclosure Schedule Updates.
         --------------------------------------------------

     (a) Upon  reasonable  notice,  the  Company  shall  afford  Parent  and its
accountants,  legal counsel and other representatives,  reasonable access during
normal  business  hours  during the period  prior to the  Effective  Time or the
earlier  termination  of this Agreement in accordance  with its terms,  provided
that Parent contacts the Company's President or Chief Financial Officer prior to
contacting  any  other  employee  of the  Company,  to:  (i)  review  all of the
Company's properties,  books,  contracts,  commitments and records, and (ii) all
other  information  concerning  the  business,  properties  and personnel of the
Company as Parent may request.  The Company  agrees to provide to Parent and its
accountants,   legal  counsel  and  other  representatives  copies  of  internal
financial  statements,  Tax  Returns and other  business  and Tax  analysis  and
documentation promptly upon request.

     (b) No information  or knowledge  obtained in any  investigation  after the
Execution  Date pursuant to this Section 5.3 shall affect or be deemed to modify
any  representation  or  warranty  contained  herein  or the  conditions  to the
obligations of the parties to consummate the Merger; provided,  however that the
Company shall  promptly  inform  Parent of any event or  occurrence  which would
reasonably be likely to have a Company  Material  Adverse Effect.  Additionally,
during the period  from the date hereof and prior to the  Effective  Time or the
earlier  termination of this Agreement in accordance with its terms, the Company
and Parent shall each promptly notify the other in writing of:

          (i) the discovery of any event, condition,  fact or circumstance which
causes,  caused,  constitutes  or  constituted  a  breach  of any representation
or  warranty  made  by  the  Company  or Parent in this  Agreement  or any other
agreement  contemplated  hereby  to  the  extent  that  such  event,  condition,
fact  or  circumstance  would  cause  the  conditions  in  Sections  6.2(a)  and
6.3(a) of this Agreement not to be satisfied;

          (ii) any material  breach of any covenant or obligation by the Company
or Parent;

          (iii) any event,  condition,  fact or  circumstance  that may make the
timely  satisfaction  of any  of  the covenants  or conditions set forth in this
Article V or Article VI impossible or unlikely.; and


                                       39



          (iv) any  information  necessary or  appropriate  for inclusion in the
Proxy  Statement  and  the  Registration  Statement  so  as  to make such filing
not to be misleading.

     (d) If any event,  condition,  fact or circumstances that is required to be
disclosed  pursuant  to  Section  5.3(c)  requires  any  material  change in the
Company's  Disclosure  Schedule or Parent  Disclosure  Schedule,  or if any such
event, condition,  fact or circumstance would require such a change assuming the
Company Disclosure  Schedule or Parent Disclosure  Schedule were dated as of the
date of the occurrence, existence or discovery of such event, condition, fact or
circumstances, then the Company or Parent, as applicable, shall promptly deliver
to the other party an update to its Disclosure  Schedule  specifying such change
(a "Disclosure  Schedule Update").  If, as a result of such development,  either
party has the right to terminate this Agreement pursuant to Article VII and such
party  fails to  exercise  that right  within a period of twenty (20) days after
such right accrues,  then the Disclosure  Schedule Update will be deemed to have
amended this  Agreement,  including any  appropriate  schedule  hereto,  to have
qualified the representations and warranties  contained in this Agreement above,
and to have cured any  misrepresentation  or breach of warranty  that  otherwise
might have existed hereunder by reason of the development.

     5.4 Confidentiality.
         ---------------

     (a) None of the  parties  to this  Agreement  nor any of  their  respective
directors,  officers,  employees,  agents or  representatives  may,  directly or
indirectly, disclose to any person or entity or use any Confidential Information
for  any  purpose  other  than  to  evaluate  and  consummate  the  transactions
contemplated by this Agreement. If any party hereto is requested or required (by
oral question or request for  information or documents in any legal  proceeding,
interrogatory,  subpoena,  civil  investigative,  demand, or similar process) to
disclose any  Confidential  Information,  such party shall  promptly  notify the
other  parties  hereto  so that  such  other  parties  may  seek an  appropriate
protective  order or waive  compliance  with the provisions of this Section 5.4.
If, in the absence of a protective  order or the receipt of a waiver  hereunder,
any party  hereto  is, on the  advice of  counsel,  compelled  to  disclose  any
Confidential   Information   to  any  tribunal   such  party  may  disclose  the
Confidential  Information to the tribunal;  provided,  however,  that such party
shall use commercially  reasonable efforts to obtain an order or other assurance
that confidential treatment will be accorded to such portion of the Confidential
Information required to be disclosed.  In the event this Agreement is terminated
for any reason,  each party hereto shall return to the  appropriate  parties all
Confidential  Information  obtained in  connection  with the  evaluation  of the
transactions contemplated by this Agreement.

     (b)  "Confidential  Information"  means any  information  not in the public
           -------------------------
domain,  in any form,  whether  acquired  prior to or after the Execution  Date,
received  from  any  party  hereto  or any of their  respective  representatives
relating  to the  business  and  operations  of either  the  Company  or Parent,
including,  without limitation,  information regarding vendors, suppliers, trade
secrets,   training  programs,   technical  information,   contracts,   systems,
procedures, know-how, trade names, improvements, price lists, financial or other
data,  business plans,  computer programs,  software systems,  internal reports,
personnel files or any other  compilation of information,  written or unwritten,
which is or was used in the  business  of the  Company  or  Parent,  except  for

                                       40



information  (i) that was or becomes  generally  available to the public,  other
than as a result of disclosure by the party hereto  receiving such  Confidential
Information;  or (ii) that is received by a party  hereto on a  non-confidential
basis from a third party that is not prohibited from disclosing such information
by obligation to either the Company or Parent.

     5.5 Public Disclosure. The Company and Parent shall consult with each other
         -----------------
before  issuing any press  releases or otherwise  make any public  statements or
make any other  public  (or  non-confidential)  disclosures  (whether  or not in
response  to  an  inquiry)  regarding  the  terms  of  this  Agreement  and  the
transactions contemplated hereby, and, to the extent possible, prepare and issue
press  releases  jointly.  Neither  the  Company  nor Parent  will issue a press
release or make any statements or disclosures without the prior written approval
of the other (which consent shall not be unreasonably  withheld),  except as may
be required by law or by obligations  pursuant to any listing agreement with any
national securities exchange or with Nasdaq (in which case, the disclosing party
shall  provide the other  parties  hereto with at least one (1)  business  days'
advance notice and a written copy of such disclosure).

     5.6 Consents; Cooperation.
         ---------------------

     (a) Each of Parent and the Company  shall  promptly  apply for or otherwise
seek,  and use  commercially  reasonable  efforts to obtain,  all  consents  and
approvals  required to be obtained by it for the consummation of the Merger. The
Company  and Parent  shall  each use their  respective  commercially  reasonable
efforts to obtain all necessary  consents,  waivers and  approvals  under any of
their respective  material contracts in connection with the Merger to the extent
required under such contracts.

     (b) The Company shall furnish Parent, on or prior to the Closing Date, with
evidence  satisfactory  to it of the consent or approval of those  Persons whose
consent or approval  shall be required in  connection  with the Merger under the
Material Contracts.

     5.7  Affiliates.  Schedule  5.7 sets forth those  persons who may be deemed
          ----------
"affiliates"  of the Company as such term is used in the  Securities Act and the
regulations  thereunder.  The Company shall provide Parent with such information
and documents as Parent shall reasonably  request for purposes of reviewing such
list.  Parent and  Merger Sub shall  include  such  persons in the  Registration
Statement  pursuant to Item 7 of Form S-4 and maintain the  effectiveness of the
Registration Statement until the completion of distribution by such persons.

     5.8 Voting  Agreement.  The Company shall use its  commercially  reasonable
         -----------------
efforts,  on behalf of Parent,  and pursuant to the request of Parent,  to cause
Asset Value Fund Limited  Partnership  to execute and deliver to Parent a Voting
Agreement substantially in the form attached hereto as Exhibit A.

     5.9 Legal Requirements. Each of Parent and, subject to Sections 4.3 and 5.1
         ------------------
of this Agreement,  the Company,  shall take all reasonable actions necessary to

                                       41



comply  promptly with all legal  requirements  which may be imposed on them with
respect to the consummation of the  transactions  contemplated by this Agreement
and will promptly  cooperate  with and furnish  information  to any party hereto
necessary in connection with any such requirements imposed upon such other party
in connection  with the  consummation of the  transactions  contemplated by this
Agreement  and will take all  reasonable  actions  necessary to obtain (and will
cooperate  with the other parties  hereto in obtaining)  any consent,  approval,
order or authorization of, or any registration,  declaration or filing with, any
Governmental  Entity  or  other  Person,  required  to be  obtained  or  made in
connection  with  the  taking  of any  action  contemplated  by this  Agreement,
including,   without  limitation,  the  Environmental  Approvals  set  forth  on
Schedules 2.10(b)(ii) and 3.9(b).

     5.10 Assumption of Company Options.
          -----------------------------

     (a) At the  Effective  Time,  each  Company  Option  which  is  outstanding
immediately  prior to the Effective Time shall become and represent an option to
purchase the number of shares of Parent  Common Stock (a  "Substitute  Option"),
increased to the nearest whole share,  determined by  multiplying  the number of
shares of Company Common Stock subject to such Company Option  immediately prior
to the Effective Time by the Exchange  Ratio,  at an exercise price per share of
Parent Common Stock,  increased to the nearest whole cent, equal to the exercise
price  per  share  of  Company  Common  Stock  subject  to such  Company  Option
immediately prior to the Effective Time divided by the Exchange Ratio.

     (b) After the Effective  Time,  except as otherwise  expressly  provided in
this Agreement,  each Substitute Option shall be exercisable upon the same terms
and conditions  (including  vesting schedules) as were applicable to the related
Company Option immediately prior to the Effective Time.

     5.11 Form S-8. Parent shall take all corporate  action necessary to reserve
          --------
for issuance a sufficient  number of shares of Parent  Common Stock for delivery
upon the  exercise of the Company  Options  assumed in  accordance  with Section
5.10.  As soon as  practicable  and in no event more than twenty (20) days after
the Closing Date, Parent shall file a registration statement on Form S-8 (or any
successor  or other  appropriate  forms)  with  respect  to the shares of Parent
Common  Stock  subject  to  such  options  or on  another  appropriate  form  of
registration  statement for any such shares of Parent Common Stock which are not
registrable  on Form S-8 and shall use its  commercially  reasonable  efforts to
maintain  the  effectiveness  of such  registration  statement  or  registration
statements  (and maintain the current status of the  prospectus or  prospectuses
contained therein) for so long as such options remain  outstanding.  The Company
will  cooperate  and  assist  Parent  in the  preparation  of such  registration
statement(s).

     5.12 Treatment as Reorganization. Neither the Company nor Parent shall take
          ---------------------------
any action prior to or following the Closing that would cause the merger to fail
to qualify as a  "reorganization"  within the  meaning of Section  368(a) of the
Code.

     5.14 Takeover Statutes.  If any Takeover Statute shall become applicable to
          -----------------
the  transaction  contemplated  hereby,  the Company and the Company's  Board of

                                       42



Directors  shall grant such  approvals and take such actions as are necessary so
that the Merger and the  transactions  contemplated  hereby may be  commenced as
promptly as  practicable on the terms  contemplated  hereby and otherwise act to
eliminate  or  minimize  the  effects  of  such  statute  or  regulation  in the
transaction  contemplated  hereby,  except,  in each such  case,  to the  extent
required  in the  exercise of the  fiduciary  duties of the  Company's  Board of
Directors under applicable law as advised by independent counsel.

     5.15  Employee  Notices.   In  connection  with  the  consummation  of  the
           -----------------
transactions  contemplated  by this  Agreement  and to the  extent  required  by
applicable law, the Company shall give all material notices required to be given
to the employees of the Company.

     5.16 Listing of Additional  Shares.  Parent  shall,  prior to the Effective
          -----------------------------
Time, cause all shares of Parent Common Stock to be issued pursuant to the terms
of this  Agreement  to be  approved  for  listing on AMEX or Nasdaq,  subject to
official notice of issuance.

     5.17 Lease  Estoppel  Certificate.  The Company  will use its  commercially
          ----------------------------
reasonable  effort to obtain,  with respect to the Lease to the Leased Premises,
an estoppel certificate from the landlord.

     5.18 Further  Assurances.  Parent,  Merger Sub and, subject to Sections 4.3
          -------------------
and 5.1 of this  Agreement,  the  Company,  shall  use  commercially  reasonable
efforts to effectuate the  transactions  contemplated  hereby and to fulfill and
cause to be fulfilled the conditions to closing under this Agreement. Each party
hereto,  at the  reasonable  request of another party hereto,  shall execute and
deliver such other  instruments and do and perform such other acts and things as
may be necessary or desirable for effecting  completely the consummation of this
Agreement and the transactions contemplated hereby.

                                   ARTICLE VI

                            CONDITIONS TO THE MERGER

     6.1  Conditions  to  Obligations  of Each Party to Effect the  Merger.  The
          ----------------------------------------------------------------
respective  obligations of each party to this Agreement to consummate and effect
this Agreement and the transactions  contemplated hereby shall be subject to the
satisfaction  at or  prior  to  the  Closing  Date  of  each  of  the  following
conditions,  any of which may be waived,  in writing,  by  agreement  of all the
parties hereto:

     (a)  Shareholder  Approval.  This  Agreement and the Merger shall have been
          ---------------------
approved  and  adopted by the  requisite  vote of the  shareholders  of both the
Company and Parent.

     (b)  Registration  Statement.  The SEC shall have declared the Registration
          -----------------------
Statement  "effective" in accordance  with the provisions of the Securities Act,
and shall be  effective  at the  Effective  Time,  and no stop order  suspending

                                       43



effectiveness of the Registration  Statement shall have been issued,  no action,
suit,  proceedings  or  investigation  by the SEC to suspend  the  effectiveness
thereof shall have been initiated and be continuing.

     (c) No  Injunctions  or Restraints;  Illegality.  No temporary  restraining
         -------------------------------------------
order, preliminary or permanent injunction or other order issued by any court of
competent  jurisdiction  or other legal or regulatory  restraint or  prohibition
preventing  the  consummation  of the Merger  shall be in effect,  nor shall any
proceeding   brought  by  an  administrative   agency  or  commission  or  other
governmental  authority  or  instrumentality,  domestic  or  foreign  (which has
jurisdiction  over the  Company or  Parent),  seeking  any of the  foregoing  be
pending; nor shall there be any action taken, or any statute,  rule,  regulation
or order enacted,  entered,  enforced or deemed applicable to the Merger,  which
makes the  consummation  of the Merger  illegal.  In the event an  injunction or
other order shall have been issued,  each party  agrees to use its  commercially
reasonable efforts to have such injunction or other order lifted.

     (d) Governmental  Approvals.  Parent, Merger Sub and the Company shall have
         -----------------------
timely  obtained  from each  Governmental  Entity  all  approvals,  waivers  and
consents, if any, necessary for consummation of the transactions contemplated by
the Merger,  including but not limited to the  expiration or  termination of any
applicable  waiting  period  under  any  applicable   antitrust  laws  and  such
approvals,  waivers and consents as may be required under the Securities Act and
state blue sky laws.


     6.2 Additional Conditions to Obligations of Company. The obligations of the
         -----------------------------------------------
Company  to  consummate   and  effect  this   Agreement  and  the   transactions
contemplated  hereby  shall be  subject to the  satisfaction  at or prior to the
Closing Date of each of the following conditions, any of which may be waived, in
writing, by the Company:

     (a) Representations,  Warranties and Covenants.  Except as disclosed in the
         ------------------------------------------
Parent  Disclosure  Schedule dated the Execution Date and as amended pursuant to
Section  5.3(d),  (i) the  representations  and  warranties  of  Parent  in this
Agreement  shall be true and correct in all  material  respects on and as of the
Closing Date as though such  representations  and warranties were made on and as
of such time and, in the case of representations  and warranties of Parent which
speak  specifically as of an earlier date,  shall be true and correct as of such
earlier date, except in each case, (A) for changes contemplated by the Agreement
or (B)  if any  portion  of any  such  representation  or  warranty  is  already
qualified by materiality, for purposes of determining whether this condition has
been satisfied with respect to such portion of such  representation or warranty,
such portion of such representation or warranty as so qualified must be true and
correct in all  respects;  and (ii) Parent shall have  performed and complied in
all material  respects with all  covenants,  obligations  and conditions of this
Agreement required to be performed and complied with by Parent as of the Closing
Date.


     (b) AMEX or Nasdaq  Listing.  The shares of Parent Common Stock issuable to
         -----------------------
the Company's shareholders in connection with the Merger and the exercise of the
Company  Options  shall  have been  authorized  for  listing  on AMEX or Nasdaq,
subject to official notice of issuance.

     (c) No Parent Material  Adverse  Effect.  There shall not have occurred any
         -----------------------------------
Parent Material Adverse Effect since the Execution Date.

                                       44



     (d)  Certificate  of Parent.  The Company  shall have been  provided with a
          ----------------------
certificate  executed on behalf of Parent by an authorized officer to the effect
set forth in Sections 6.2(a), (b) and (c).

     (e) Third Party  Consents.  Parent  shall have  obtained  all the  consents
         ---------------------
required by the Parent Contracts Requiring Novation or Consent.

     6.3 Additional  Conditions to the Obligations of Parent. The obligations of
         ---------------------------------------------------
Parent to consummate and effect this Agreement and the transactions contemplated
hereby shall be subject to the  satisfaction  at or prior to the Closing Date of
each of the following  conditions,  any of which may be waived,  in writing,  by
Parent:

     (a) Representations,  Warranties and Covenants.  Except as disclosed in the
         ------------------------------------------
Company Disclosure  Schedule dated the Execution Date and as amended pursuant to
Section  5.3(d),  (i) the  representations  and  warranties  of  Company in this
Agreement  shall be true and correct in all  material  respects on and as of the
Closing Date as though such  representations  and warranties were made on and as
of such time and, in the case of  representations  and warranties of the Company
which speak  specifically as of an earlier date, shall be true and correct as of
such earlier  date,  except in each case,  (A) for changes  contemplated  by the
Agreement,  or (B) if any  portion of any such  representation  or  warranty  is
already  qualified  by  materiality,  for purposes of  determining  whether this
condition has been satisfied with respect to such portion of such representation
or  warranty,  such portion of such  representation  or warranty as so qualified
must be true and  correct  in all  respects;  and (ii) the  Company  shall  have
performed and complied in all material respects with all covenants,  obligations
and conditions of this  Agreement  required to be performed and complied with by
it as of the Closing Date.


     (b)  Certificate  of  Company.  Parent  shall  have  been  provided  with a
          ------------------------
certificate  executed  on behalf of Company by its  President  to the effect set
forth in Section 6.3(a).

     (c)  Dissenters.  The  holders  of no more  than five  percent  (5%) of the
          ----------
outstanding  shares of  Company  Capital  Stock  shall  have  either  elected to
exercise their rights to dissent from the Merger and shall have not  effectively
lost or  withdrawn  such  dissenters  rights or shall  otherwise  be entitled to
exercise their rights to dissent from the Merger and shall have not  effectively
lost or withdrawn their right to exercise such dissenters rights.

     (d) Third Party Consents.  The Company shall have obtained all the consents
         --------------------
required  by the Company  Contracts  Requiring  Novation or Consent,  including,
without limitation, Heller Healthcare Finance, Inc.

     (e) Suppliers and Customers.  Parent shall have had the opportunity to meet
         -----------------------
with the  Company's  key  suppliers  and  customers  listed on Schedule 2.20 and
reasonably  satisfy itself with respect to the Company's  ongoing  relationships
with such parties.  Parent shall only meet with such parties with Kelly Scott or
other  designee  of the  Company.  This  condition  shall be deemed to have been
automatically  satisfied on the 30th day after the Execution Date, unless Parent
notifies the Company in writing of any reasonable objection.

                                       45



     (f) Company  Material  Adverse  Effect.  There shall not have  occurred any
         ----------------------------------
Company Material Adverse Effect since the Execution Date.

                                   ARTICLE VII

                        TERMINATION, AMENDMENT AND WAIVER

     7.1 Termination.
         -----------

     (a) At any time  prior  to the  Effective  Time,  whether  before  or after
approval  of  the  matters  presented  in  connection  with  the  Merger  by the
shareholders  of the Company,  and subject to Section 7.3 below,  this Agreement
may be terminated:

          (i) by mutual written consent duly authorized by each party's Board of
Directors;

          (ii) by either  Parent or the  Company,  if (A) the Closing  shall not
have  occurred  on  or  before  January  31,  2003;  provided  that  the parties
shall  reasonably  agree  to  extend  this date  for up  to thirty (30) days, so
long  as  the  party  requesting  such  extension   has  used  its  commercially
reasonable  efforts  to  diligently  perform  each of its obligations under this
Agreement  in  good  faith;  and provided  further  that the  right to terminate
this  Agreement  under this  Section  7.1(a)(ii) shall  not be  available to any
party  whose  action  or  failure  to  act  has been the cause of the failure of
the   Merger to  occur on  or  before  such  date and such  action or failure to
act  constitutes  a  breach  of  this Agreement, (B) any permanent injunction or
other  order  of  a  court  or   other   competent   authority  preventing   the
consummation  of the  Merger  shall  have become  final  and  nonappealable,  or
(C) if any required  approval  of  the  shareholders of  the  Company  or Parent
shall  not  have  been  obtained  by  reason  of  the  failure   to  obtain  the
required  votes  at  either   the  Company   Shareholders   Meeting   or  Parent
Shareholders Meeting or at any adjournment thereof.


          (iii) by  Parent,  if (A) the  Company  shall  materially  breach  any
representation,  warranty,  obligation  or  agreement  hereunder  (other  than a
breach   of  Section  4.3(a)  hereof  which   is   specifically   addressed   in
subsection  (v)  below  or  a  breach  which  has  not   had,  and   would   not
reasonably  be  expected  to  result  in, a Company Material Adverse Effect) and
such  breach shall  not have  been  cured  within  twenty (20)  business days of
receipt  by  the  Company  of  written  notice  of such breach  (describing  the
details  of  such  breach) provided  that  the right to terminate this Agreement
by  Parent  under  this  Section  7.1(a) (iii)(A)  shall  not  be  available  to
Parent  where  Parent is  at  that  time  in breach of this  Agreement,  (B) the
Board  of  Directors  of  the  Company  shall  have  withdrawn  or  modified its
recommendation  of  this  Agreement  or  the  Merger  in  a  manner  adverse  to
Parent  or  recommended,  endorsed, accepted  or  agreed  to a Takeover Proposal

                                       46



or  shall  have  resolved  to  do  any  of  the  foregoing,  (C) the   Board  of
Directors  of  the  Company  shall  have  publicly  announced  a  rejection of a
Takeover  Proposal,  but  failed  to  give Parent a written reaffirmation of its
recommendation  of  this  Agreement,  the  Merger  and  the  other  transactions
contemplated   hereby  within  five  (5)  business  days  of   Parent's  request
thereof   following   the    rejection  of   such    Takeover    Proposal   (the
"Reaffirmation"),  (D)  a  Trigger  Event  is commenced (other than by Parent or
an  affiliate  of  Parent)  and  the  Board  of  Directors  of  the  Company (x)
recommends  that  the  shareholders  of the  Company tender their shares in such
tender  or  exchange  offer;  or (y) within  ten (10)  days after such tender or
exchange   offer,  fails  to  recommend  against   acceptance  of  such offer or
takes  no  position  with respect  to  the  acceptance of such Trigger Event and
fails  to  deliver  to  Parent  a Reaffirmation within five (5) business days of
Parent's  request  therefore;  or (E)  for  any reason (other than as the result
of  the  failure  of  Parent  to perform its obligations  under this Agreement),
the  Company  fails  to  call  and  hold  the  Company  Shareholders  Meeting by
January 21, 2003;

          (iv)  by the  Company,  if (A)  Parent  shall  materially  breach  any
representation,   warranty,  obligation  or  agreement  hereunder (other  than a
breach  which  has  not  had, and  would  not  reasonably  be expected to result
in,  a  Parent  Material  Adverse  Effect) and  such  breach shall not have been
cured  within  twenty  (20)  business  days  of  receipt  by  Parent  of written
notice  of  such  breach  (describing  the details of such breach) provided that
the  right  to   terminate   this   Agreement  by  Company  under  this  Section
7.1(a) (iv)(A) shall  not  be  available  to the Company where the Company is at
that time  in  material  breach of  this  Agreement,  (B) the Board of Directors
of  Parent  shall  have  withdrawn  or  modified   its  recommendation  of  this
Agreement  or  the  Merger  in  a  manner  adverse to the  Company or shall have
resolved  to  do  the foregoing,  or  (C) the  Board of Directors of the Company
shall  recommend,  endorse,  accept  or  agree  to  a Superior Proposal or shall
have  resolved   to  recommend,  endorse,   accept  or   agree  to  a   Superior
Proposal; or

          (v) by Parent if the Company or its officers, directors,  employees or
representatives  have  willfully  breached  or  violated  the   restrictions  of
Section 4.3(a).

     (b) As used herein,  a "Trigger  Event" means any event after the Execution
                             --------------
Date in which any Person  commences a tender or exchange  offer,  the successful
consummation   of  which  would  result  in  the  offeror  and  its   affiliates
beneficially owning securities representing thirty-five percent (35%) or more of
the voting power of Company.

     7.2 Effect of Termination. In the event of termination of this Agreement as
         ---------------------
provided in Section 7.1, this Agreement  shall  forthwith  become void and there
shall be no liability or obligation  on the part,  of Parent,  Merger Sub or the
Company or their  respective  officers,  directors,  shareholders or affiliates,
except to the extent that such termination  results from the willful breach by a
party hereto of any of its representations, warranties or covenants set forth in
this  Agreement;  provided that,  notwithstanding  the above,  the provisions of
Section 5.4  (Confidentiality),  this Section 7.2 and Section 7.3  (Expenses and
Termination  Fees)  shall  remain  in full  force and  effect  and  survive  any
termination  of this  Agreement and Parent's right to a remedy for the Company's
breach of Section 4.3 shall survive any termination of this Agreement.

                                       47



     7.3 Expenses and Termination Fees.
         -----------------------------

     (a) Subject to Sections  7.3(b),  (c) and (d), whether or not the Merger is
consummated,  all costs and expenses  incurred in connection with this Agreement
and the transactions  contemplated hereby (including,  without  limitation,  the
fees and expenses of its advisers,  accountants and legal counsel) shall be paid
by the party incurring such expense.

     (b) In the event that this  Agreement  is  terminated  in  accordance  with
Section  7.1(a)(iii),  (iv)(A),  (iv)(B)  or (v),  then the  party  entitled  to
terminate this Agreement  pursuant to such provisions (the "Terminating  Party")
shall be paid by the non-Terminating Party, within ten (10) business days of the
termination thereof,  the sum of $100,000 (the "Termination Fee").  Furthermore,
(x)  the  Company  shall  pay to  Parent  the  Termination  Fee  if the  Company
terminates  this Agreement  pursuant to Section  7.1(a)(iv)(C);  (y) the Company
shall pay to Parent the  Termination  Fee if Asset Value Fund,  LP or any of the
Company's  officers or directors  who own shares of Company  Common Stock do not
vote such shares in favor of the Merger and, as a result thereof,  the Company's
shareholders do not approve the Merger;  and (z) Parent shall pay to the Company
the  Termination  Fee if any of its  officers  or  directors  who own  shares of
Company Common Stock and Parent Common Stock do not vote such shares in favor of
the Merger and, as a result thereof, the Company's  shareholders or the Parent's
shareholders do not approve the Merger.

     (c) In addition to the fees payable  pursuant to Section  7.3(b) above,  in
the event that the Company or Parent (hereinafter, a "Selling Company") accepts,
in  writing,  an offer for the sale,  merger or exchange of any of its shares or
the sale of all or  substantially  all of its assets from any  entity,  party or
group,  other than Parent in the case of the Company,  prior to the later of (i)
March 15, 2003 or (ii) provided that notice of the Company  Shareholders Meeting
and the Parent  Shareholders  Meeting,  as  applicable,  have been given and not
withdrawn  prior to March 15, 2003,  the vote of their  respective  shareholders
relating to the Merger, regardless of whether such acceptance is approved by the
Board of  Directors  of the Selling  Company,  the  shareholders  of the Selling
Company,  or such  transaction is  consummated,  then the Selling  Company shall
immediately  upon such  acceptance pay to the non-Selling  Company,  in cash, an
amount  equal to five  percent  (5%) of the total  consideration  (whether  such
consideration is to be paid in cash,  securities or other property) of the offer
accepted by the Selling  Company (the "Break-Up  Fee").  The Break-Up Fee is due
and payable even if this Agreement is terminated by either party hereto prior to
the acceptance of such third party offer;  provided that no Break-Up Fee will be
paid to any party who takes any action, contrary to the terms of this Agreement,
to willfully avoid consummating the transactions contemplated by this Agreement.
In the event the non-Selling  Company is in material breach of this Agreement at
the time an  offer is  accepted  by the  Selling  Company,  any  payment  of the
Break-Up Fee by the Selling  Company shall not constitute a waiver or release of
the non-Selling Company's liability for damages arising from such breach and the
Selling Company reserves all rights to seek recovery  thereof.  The Break-Up Fee
will accrue  interest at twelve  percent (12%) per annum from the date it is due
until paid in full and the Selling Company hereby  acknowledges that such action
will constitute  irreparable harm to the other party and further agrees that the
non-Selling Company will be entitled to obtain an affirmative injunction, in any

                                       48



court of competent jurisdiction, which would enjoin the consummation of any such
sale of the Selling  Company's  shares or assets  until the Break-Up  Fee,  with
interest,  is paid in full.  Upon payment of the Break-Up Fee (together with any
accrued  interest  specified  in this  Section  7.3(c) and any  attorney's  fees
specified in Section 8.11) and the Termination  Fee, if applicable in accordance
with Section 7.3(b), notwithstanding Section 7.2, the Selling Company shall have
no further liability or obligation with respect to this Agreement; provided that
if the Selling Company commences an action against the non-Selling  Company then
the  non-Selling  Company shall be entitled to assert any and all  counterclaims
hereunder and the Selling  Company shall be liable for all damages in connection
with such counterclaims including attorney's fees under Section 8.11 hereof.

     7.4 Amendment. The Boards of Directors of the parties hereto may cause this
         ---------
Agreement  to be amended at any time by execution  of an  instrument  in writing
signed on behalf of each of the parties hereto;  provided that an amendment made
subsequent to adoption of the Agreement by the  shareholders  of the Company and
Parent shall not (i) alter or change the amount or kind of  consideration  to be
received on conversion of the Company  Capital  Stock,  (ii) alter or change any
term of the Articles of Incorporation of Surviving Corporation to be effected by
the  Merger,  or (iii)  alter or change any of the terms and  conditions  of the
Agreement,  if such alteration or change would  materially  adversely affect the
holders of Company Capital Stock.

     7.5  Extension;  Waiver.  At any time prior to the Effective Time any party
          ------------------
hereto  may,  to the  extent  legally  allowed,  (i)  extend  the  time  for the
performance of any of the obligations or acts of the other parties hereto,  (ii)
waive any inaccuracies in the  representations and warranties made to such party
contained  herein or in any document  delivered  pursuant hereto and (iii) waive
compliance with any of the agreements or conditions for the benefit of the other
party contained herein.  Any agreement on the part of a party hereto to any such
extension or waiver shall be valid only if set forth in an instrument in writing
signed on behalf of such party  granting  such waiver or extension  and only for
the specific instance for which such waiver or extension was granted.

     7.6 No Right to Terminate.  No party may refuse to perform its  obligations
         ---------------------
under this Agreement or terminate this Agreement on the basis that any condition
remains  unsatisfied where such party's failure to fulfill its obligations under
this  Agreement  shall have been the cause of, or resulted in, the condition not
being satisfied.

                                  ARTICLE VIII

                               GENERAL PROVISIONS

     8.1  Non-Survival  at Effective Time. The  representations,  warranties and
          -------------------------------
agreements of each of the parties set forth in this Agreement shall terminate at
the Effective  Time,  except that the agreements set forth in Article I, Section
5.4  (Confidentiality),  Section 5.10 (Assumption of Company  Options),  Section
5.11 (Form S-8),  Section 5.18 (Further  Assurances),  Section 7.3 (Expenses and
Termination Fees), Section 7.4 (Amendment),  and this Article VIII shall survive
the Effective Time.

                                       49



     8.2  Notices.   All  notices,   requests,   demands,   consents  and  other
          -------
communications  required or permitted to be given or made hereunder  shall be in
writing  and  shall be deemed to have  been  duly  given  and  received,  (a) if
delivered by hand, the day it is so delivered against receipt, (b) if mailed via
the United States mail,  certified  first class mail,  postage  prepaid,  return
receipt  requested,  five business days after it is mailed,  or (c) if sent by a
nationally  recognized  overnight courier, the business day after it is sent, to
the party to whom the same is so given or made,  at the address of such party as
set forth  below,  which  address  may be changed  by notice to the other  party
hereto duly given as set forth herein):

     (a)      if to Parent or Merger Sub, to:
              CardioTech International, Inc.
              78 E. Olympia Avenue
              Woburn, Massachusetts  01801-4722
              Facsimile:  (781) 937-4218
              Attn:  Michael Szycher

              with a copy to:
              Ellenoff Grossman Schole & Cyruli, LLP
              370 Lexington Avenue
              19th Floor
              New York, New York  10019
              Facsimile:  (212) 370-7889
              Attn:  Barry I. Grossman, Esq.

     (b)      if to the Company, to:
              Gish Biomedical, Inc.
              22942 Arroyo Vista
              Rancho Santa Margarita, California  92688
              Facsimile:  (949) 635-6299
              Attn:  Kelly D. Scott


              with a copy to:
              Gibson, Dunn & Crutcher LLP
              Jamboree Center
              4 Park Plaza
              Irvine, California  92614
              Facsimile:  (949) 451-4220
              Attn:  John M. Williams, Esq.

     8.3 Interpretation;  Certain Definitions.  When a reference is made in this
         ------------------------------------
Agreement to Exhibits,  such reference  shall be to an Exhibit to this Agreement
unless otherwise indicated. The words "include," "includes" and "including" when
used herein  shall be deemed in each case to be  followed by the words  "without
limitation."  The phrase "made  available" in this Agreement shall mean that the
information  referred to has been made  available  if  requested by the party to
whom such  information  is to be made  available.  The phrases "the date of this

                                       50



Agreement",  "the date hereof", and terms of similar import,  unless the context
otherwise  requires,  shall be deemed to refer to the Execution  Date.  The term
"Person"   shall  mean  any   corporation,   partnership,   individual,   trust,
unincorporated  association  or other  entity or Group  (within  the  meaning of
Section  13(d)(3)  of the  Exchange  Act).  The table of contents  and  headings
contained in this Agreement are for reference purposes only and shall not affect
in any way the meaning or interpretation of this Agreement.

     8.4 Counterparts; Facsimile Delivery. This Agreement may be executed in one
         --------------------------------
or  more  counterparts  and  delivered  by  facsimile,  all of  which  shall  be
considered  one and the same  agreement and shall become  effective  when one or
more  counterparts  have been signed by each of the parties and delivered to the
other  parties,  it being  understood  that all  parties  need not sign the same
counterpart.

     8.5 Entire Agreement; Nonassignability; Parties in Interest. This Agreement
         -------------------------------------------------------
and the documents and instruments and other agreements  specifically referred to
herein or delivered  pursuant  hereto,  including the Exhibits,  the  Schedules,
including the Company  Disclosure  Schedule and the Parent Disclosure  Schedule,
(a)  constitute  the entire  agreement  among the  parties  with  respect to the
subject  matter hereof and supersede all prior  agreements  and  understandings,
both  written and oral,  among the parties  with  respect to the subject  matter
hereof, except for the Confidentiality  Agreement,  which shall continue in full
force and effect,  and shall survive any  termination  of this  Agreement or the
Closing,  in accordance with its terms,  (b) are not intended to confer upon any
other Person any rights or remedies  hereunder,  except as set forth in Sections
1.6(a) - (g), 1.7, 1.10, 5.7, 5.10, 5.11 and 5.12, and (c) shall not be assigned
by  operation  of law or otherwise  except as  otherwise  specifically  provided
herein.

     8.6 Severability. In the event that any provision of this Agreement, or the
         ------------
application thereof, becomes or is declared by a court of competent jurisdiction
to be illegal,  void or  unenforceable,  the  remainder of this  Agreement  will
continue in full force and effect and the application of such provision to other
persons or  circumstances  will be  interpreted  so as  reasonably to effect the
intent of the parties hereto.  The parties further agree to replace such void or
unenforceable provision of this Agreement with a valid and enforceable provision
that will achieve,  to the extent  possible,  the  economic,  business and other
purposes of such void or unenforceable provision.

     8.7  Remedies   Cumulative.   Except  as  otherwise  provided  herein  (and
          ---------------------
specifically with respect to the remedy provided upon a termination by any party
pursuant to Section  7.3(b)),  any and all remedies herein  expressly  conferred
upon a party  will be  deemed  cumulative  with and not  exclusive  of any other
remedy conferred  hereby,  or by law or equity upon such party, and the exercise
by a party of any one remedy will not preclude the exercise of any other remedy.

     8.8  Governing  Law. This  Agreement  shall be governed by and construed in
          --------------
accordance  with the laws of the State of  Delaware  without  reference  to such
state's  principles of conflicts of law. Each of the parties hereto  irrevocably
consents to the  jurisdiction of any court located within the State of Delaware,
in connection with any matter based upon or arising out of this Agreement or the
matters contemplated herein,  agrees that process may be served upon them in any

                                       51



manner  authorized  by the laws of the State of  Delaware  for such  persons and
waives  and  covenants  not to assert or plead any  objection  which  they might
otherwise  have to such  jurisdiction  and  such  process.  THE  PARTIES  HERETO
IRREVOCABLY  WAIVE THE RIGHT TO A JURY  TRIAL IN  CONNECTION  WITH ANY  ACTIONS,
SUITS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE MERGER OR
THE TRANSACTIONS CONTEMPLATED HEREBY.

     8.9 Rules of  Construction.  The parties  hereto  agree that they have been
         ----------------------
represented by counsel during the negotiation, preparation and execution of this
Agreement and, therefore, waive the application of any law, regulation,  holding
or rule of  construction  providing  that  ambiguities  in an agreement or other
document  will be  construed  against  the  party  drafting  such  agreement  or
document.

     8.10 Assignment. Neither this Agreement nor any of the rights, interests or
          ----------
obligations  hereunder shall be assigned by any of the parties hereto,  in whole
or in part (whether by operation of law or otherwise), without the prior written
consent of the other party, and any attempt to make any such assignment  without
such consent  shall be null and void.  Subject to the preceding  sentence,  this
Agreement  will be binding upon,  inure to the benefit of and be  enforceable by
the parties and their respective successors and assigns.

     8.11  Attorneys'  Fees.  In any  action at law or suit in equity to enforce
           ----------------
this  Agreement  or the rights or  remedies  any of the parties  hereunder,  the
prevailing party in such action or suit shall be entitled to receive a sum equal
to all reasonable  attorneys' fees and all other costs and expenses  incurred in
connection with such action or suit.

                     [Signatures Follow On A Separate Page]














                                       52



     IN WITNESS  WHEREOF,  the  Company,  Parent and Merger Sub have each caused
this  Agreement  to be  executed  and  delivered  by their  respective  officers
thereunto duly authorized, all as of the date first written above.

                                  THE COMPANY:

                                  Gish Biomedical, Inc.,

                                  a California corporation

                                  By:      /s/ Kelly D. Scott
                                           ----------------------------------

                                  Name:    Kelly D. Scott
                                           ----------------------------------

                                  Title:   President and Chief Executive Officer

                                  PARENT:

                                  CardioTech International, Inc.,
                                  a Massachusetts corporation

                                  By:      /s/ Michael Szycher
                                           ---------------------------------

                                  Name:    Michael Szycher
                                           ---------------------------------

                                  Title:   Chief Executive Officer
                                           ---------------------------------


                                  MERGER SUB:

                                  Gish Acquisition Corp.,
                                  a Delaware corporation

                                  By:      /s/ Michael Szycher
                                           ---------------------------------

                                  Name:    Michael Szycher
                                           ---------------------------------

                                  Title:   Chief Executive Officer
                                           ---------------------------------



                                SIGNATURE PAGE TO
                 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION


                                       53



                                                                      Exhibit A

                                VOTING AGREEMENT

     VOTING AGREEMENT made as of this 25th day of October,  2002, by ASSET VALUE
FUND LIMITED  PARTNERSHIP  ("AVF") and ASSET VALUE  MANAGEMENT,  INC. ("AVM") in
favor of CARDIOTECH INTERNATIONAL, INC. ("Cardiotech").

                              W I T N E S S E T H:

     WHEREAS,  Cardiotech,  Gish  Acquisition  Corp. and Gish  Biomedical,  Inc.
("Gish")  have entered into an Agreement  and Plan of Merger and  Reorganization
dated October 25, 2002 (the "Merger Agreement");

     WHEREAS,  each of the  undersigned  will  receive  substantial  direct  and
indirect  benefit  by  reason  of  the  consummation  of the  transactions  (the
"Merger") provided for in the Merger Agreement;

     WHEREAS, each of the undersigned is the record and beneficial owner of such
number of shares of capital  stock of Gish as of the date hereof as set forth in
Exhibit A hereto and will receive  shares of capital  stock of  Cardiotech  as a
result of the consummation of the Merger;

     WHEREAS,  each  of the  undersigned  has  determined  that  its  execution,
delivery and performance of this Voting Agreement  directly benefit,  and are in
its best interests; and

     WHEREAS,  it is a  condition  precedent  to  the  entering  of  the  Merger
Agreement  by  Cardiotech  and the  consummation  of the Merger that each of the
undersigned  shall  have  executed  and  delivered  to  Cardiotech  this  Voting
Agreement.

     NOW, THEREFORE, in consideration of the premises and the agreements herein,
and in order to induce  Cardiotech  to enter  into the Merger  Agreement  and to
consummate the Merger,  the undersigned,  intending to be legally bound,  hereby
agree with Cardiotech as follows:

     1.  Definitions.  Reference is hereby made to the Merger  Agreement,  for a
statement  of the terms  thereof,  and each of the  undersigned  represents  and
warrants that it has read and reviewed the Merger  Agreement.  Unless  otherwise
defined  herein,  all terms  used in this  Voting  Agreement  and not  otherwise
defined herein shall have the meanings ascribed thereto in the Merger Agreement.

     2.  Voting  Restrictions.  For a period of three (3)  years  following  the
effectiveness  of the  Merger,  each of AVF and AVM  agrees,  for itself and its
"affiliates"  (as defined in the rules and  regulations  of the  Securities  and
Exchange Commission)  (collectively,  "Covered Persons"), that (i) he, she or it
shall vote all shares of capital stock of Cardiotech  then owned by such Covered
Person for each and every  management  nominee in any  election of  directors of



Cardiotech  and not  vote or take  any  action,  directly  or  indirectly,  as a
shareholder of Cardiotech, which would have the effect of removing any member of
the Board of Director of Cardiotech from office,  and (ii) all Covered  Persons,
in the  aggregate,  shall  nominate  no more than one (1) person to serve on the
Board of Directors of Cardiotech.

     3. Exceptions. The restrictions provided in Section 2 above shall not apply
if:  (i) on the date the  Covered  Person  wishes to act  contrary  to Section 2
above,  the  mathematical  average  closing  stock price of the shares of common
stock of Cardiotech for the twenty-five (25) trading days preceding such date is
less than fifty percent (50%) of the CTE Closing Price (as hereinafter defined);
and (ii) all of the  Covered  Persons  have not at any time  taken  any  "short"
positions  in the shares of capital  stock of  Cardiotech.  With  respect to any
person or entity who directly  owns an equity  interest in either AVF or AVM who
is not a Covered Person (each, an "Additional Covered Person"), the restrictions
provided  in  Section 2 above (x) will be  applicable  only to shares of capital
stock of Cardiotech  issued to AVF pursuant to the Merger (the "Merger  Shares")
and not to  additional  shares  otherwise  acquired by such  Additional  Covered
Person from any other source and (y) with respect to any Covered Person, are not
applicable to any transferee of Merger Shares who is not either a Covered Person
or an Additional Covered Person; provided that AVF and AVM each agree that prior
to  transferring  any Merger Shares to any Covered Person or Additional  Covered
Person,  they  will  require  such  transferee  to  execute  a  joinder  to this
Agreement,  in form and substance reasonably acceptable to Cardiotech,  pursuant
to which such transferee agrees to be bound by the terms hereof. Notwithstanding
anything in this Voting Agreement  suggesting the contrary,  each Covered Person
and  Additional  Covered  Person may sell shares of capital  stock of Cardiotech
(including,  without limitation, the Merger Shares) at any time to any person or
entity who is neither a Covered Person nor an Additional Covered Person free and
clear of any voting restrictions whatsoever.

     4. CTE Closing  Price.  For the  purposes of this  Voting  Agreement,  "CTE
Closing Price" shall mean $1.5124.

     5. Governing Law. This Voting  Agreement shall be governed by and construed
in accordance with the internal laws of the Commonwealth of Massachusetts.

     6.  Counterparts.  This  Voting  Agreement  may be signed in any  number of
counterparts, each of which shall be an original, with the same effect as if the
signatures thereto were upon the same instrument. Facsimile signatures shall for
all purposes hereof be deemed to be original signatures of the parties hereto.

     7. Jurisdiction.  Each of the undersigned hereby irrevocably submits to the
jurisdiction  of the state court or the federal  court  closest in  proximity to
Suffolk County, Commonwealth of Massachusetts, in any action, suit or proceeding
brought under,  in respect of or in connection with this Voting  Agreement,  and
hereby  irrevocably  waives,  to the fullest extent each of the  undersigned may
effectively  do  so,  any  defense  based  on  improper  jurisdiction  or  venue
including, without limitation, defenses based on forum non convenience.

                                       2



     8. Legal  Fees.  The  prevailing  party in any action,  suit or  proceeding
brought under, in respect of or in connection  with this Voting  Agreement shall
be  entitled  to  reasonable  attorney's  fees and costs from the other  parties
thereto.

     IN WITNESS WHEREOF, each of the undersigned has executed and delivered this
Voting Agreement in favor of Cardiotech as of the date first above written.




                            ASSET VALUE FUND LIMITED
                            PARTNERSHIP
                            By: ASSET VALUE MANAGEMENT, INC., as General Partner

                            By: /s/ Paul O. Koether
                                -------------------------------------------
                                Paul O. Koether


                            ASSET VALUE MANAGEMENT, INC.


                            By: /s/ Paul O. Koether
                                -------------------------------------------
                                Paul O. Koether























                                       3





                                    Exhibit A

                   Schedule of Ownership of Gish Capital Stock
                   -------------------------------------------

Asset Value Fund Limited Partnership                                 590,400



























                                       4